var title_f10_12_10432="MRCP mixed type IPMN";
var content_f10_12_10432=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66204&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66204&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    MRCP showing mixed-type IPMN",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 400px; height: 214px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Magnetic resonance cholangiopancreatography revealing mixed-type intraductal papillary mucinous neoplasm. There are three dilated branch ducts in the proximal pancreatic tail, with slight dilation of the main pancreatic duct just downstream.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin McGrath, MD, and Asif Khalid, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10432=[""].join("\n");
var outline_f10_12_10432=null;
var title_f10_12_10433="Five flap z-plasty";
var content_f10_12_10433=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F57321&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F57321&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 541px\">",
"   <div class=\"ttl\">",
"    Five flap Z-plasty",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 521px; height: 631px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The five flap Z-plasty is a double-opposing Z-plasty with the addition of a V-Y plasty between the two (forming D).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10433=[""].join("\n");
var outline_f10_12_10433=null;
var title_f10_12_10434="Deployment of coronary stent";
var content_f10_12_10434=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F52634&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F52634&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 480px\">",
"   <div class=\"ttl\">",
"    Deployment of coronary stent",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 460px; height: 299px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Steps involved in the deployment of a coronary stent. The first step is balloon angioplasty, which creates intimal disruption (top panel). Following placement (middle panel), the stent is expanded (bottom panel).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Cannon A, Roubin GS, Interventional Cardiovascular Medicine, Roubin GS, Califf RM, O'Neill WW, et al (Eds), Churchill Livingstone, New York, 1994, p.866.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10434=[""].join("\n");
var outline_f10_12_10434=null;
var title_f10_12_10435="Algorithm breast mass over 30";
var content_f10_12_10435=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F74666&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F74666&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 623px\">",
"   <div class=\"ttl\">",
"    Diagnostic algorithm for palpable breast abnormalities in women aged 30 years and over",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 603px; height: 784px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    When lesions are palpable, clinically directed biopsies are often the most efficient. Fine-needle aspiration (FNA) is the biopsy of choice, but if it is not available or reliable at an institution, percutaneous core biopsy can easily be substituted.",
"    <div class=\"footnotes\">",
"     BI-RADS: Breast Imaging Reporting and Data System; U/S: ultrasound; FNA: fine-needle aspiration.",
"     <br>",
"      * The asterisk indicates a situation in which it may be useful to incorporate a staging MRI into the management of a patient with breast cancer if this technique is available.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Esserman, L, et al. Current Oncology Reports 2000; 2:572.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10435=[""].join("\n");
var outline_f10_12_10435=null;
var title_f10_12_10436="Velpeau bandage";
var content_f10_12_10436=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65610&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65610&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Velpeau bandage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 536px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    To apply a Velpeau bandage, start as in A and repeat B and C until several layers are applied. The weight of the arm is supported by looping the stockinette over the shoulder and around the elbow.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Shaw, DC, Heckman, JD. Principles and techniques of splinting musculocutaneous injuries. Emerg Med Clin North Am 1984; 2:391. Copyright &copy;1984 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10436=[""].join("\n");
var outline_f10_12_10436=null;
var title_f10_12_10437="Scopolamine (systemic): Patient drug information";
var content_f10_12_10437=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Scopolamine (systemic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32375?source=see_link\">",
"     see \"Scopolamine (systemic): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/0/39941?source=see_link\">",
"     see \"Scopolamine (systemic): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9522574\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Transderm Sc��p&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9522575\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Buscopan&reg;;",
"     </li>",
"     <li>",
"      Scopolamine Hydrobromide Injection;",
"     </li>",
"     <li>",
"      Transderm-V&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024588\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691595",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help motion sickness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691974",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat muscle spasms of the GI (gastrointestinal) tract.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691522",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat upset stomach and throwing up.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024587\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702908",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to scopolamine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703742",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024592\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The patch may have metal. Take off the patch before an MRI.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man with problems passing urine, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024593\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024595\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024590\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin patch:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696192",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use skin patch behind the ear. If using for motion sickness, put on 4 hours before travel starts.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696262",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear only one patch at a time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695146",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If the patch falls off, put a new one on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695128",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If this drug is needed for more than 3 days, throw away the old patch. Put a new one on behind the other ear.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle, vein, or into the fatty part of the skin.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024591\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024596\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin patch:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024597\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12304 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-41275854C3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10437=[""].join("\n");
var outline_f10_12_10437=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522574\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9522575\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024588\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024587\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024592\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024593\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024595\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024590\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024591\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024596\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024597\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?23/58/24484?source=related_link\">",
"      Scopolamine (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?4/8/4228?source=related_link\">",
"      Scopolamine (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/56/9092?source=related_link\">",
"      Scopolamine (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32375?source=related_link\">",
"      Scopolamine (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/0/39941?source=related_link\">",
"      Scopolamine (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_12_10438="Primary ciliary dyskinesia";
var content_f10_12_10438=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F75562%7EPULM%2F77377&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F75562%7EPULM%2F77377&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Primary ciliary dyskinesia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 357px; height: 352px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cross-sectioned axoneme from a man with immotile-cilia syndrome. The dynein arms are lacking from the axoneme, resulting in immotile cilia and sperm tails.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Afzelius, BA, et al. Tissue &amp; Cell 1995; 27:241.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal ciliary structure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 301px; height: 300px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEsAS0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5Uorp/hf/AMlL8Jf9he0/9HJX6GDnNAH5mUV+m4HFLQB+Y9FfpyI9zljTsUAfmJRX6d7eegoAoA/MSiv06xnFBHNAH5i0V+nQXmkxQB+Y1Ffp0BzRigD8xaK/Tlhio2HHFAH5lUV+l8jhRk54qr9oXdySBigD82qK/SVbgZ6nHTNSNLkZGQo60AfmtRX6S/aMnAB4P6VJDMJJMKTkdqAPzWor9NVBNOK9CKAPzIor9N8Um2gD8yaK/TXbxRjFAH5lUV+mv0pKAPzLor9MyKaR7CgD8zqK/S4jmkwfSgD80qK/Spqgl78Z9KAPzcor6s/av/5J/p3vqkf/AKJlr5ToA6b4Yf8AJSvCf/YXtP8A0clfoYnPrX55/DH/AJKV4T/7C9p/6OSv0Mi5FAE44xinYzQg6Zp5oASjtRQaAEzQDQR6ZpD+VABSEimyPj6471VknAOM9aALqHJ4p2Khtn3gGpJJUjTLsAPU8UAOxSYqu95EBnePbmoY9Tt5JdiyqW9AwoAvEDFQ3EiQxtJKwSNQSWY4AFTKQygg8VxvxP1uy0vQjDfOUjuj5JIOCAQcn9KAOd8afEVrC1kl0K2j1GKFis0glwqDB5zjnoa831z4gXE/iKxNnq9mkEsAaXc52o2WyM+teealqEmoalNofh6aVNNeTBA53e55PHJ71u6r4IsdF8GyXl0ivdgAeZuIwSfSgDp5PEWtz64z6TqkdzaN8zHecDpnoansfi5qEBuGvbJJbKFtjSRufzBryXwh4a1TUrG9vLbVUsooYySrOQWHpT7HxEsPhe40prTfI7EmVup5H+FAH0f4a+IGl63Pbori185QFWU7dxOOnrXpH7i2Xe7AIP4ia+MbDxLbXuo6TDexm1jskVFkj+UgjHzcY9K1tf8AiRrYu3ht9UmaxIConBBH1oA+srLxFpV3L5VvewvJ/d3c1sghlGDkV8peDY9SWW1vVaQxSDO4MQc5r6D8M69HNbRRTy5cDHzHrigDq9o96VUJ5HOBmiNgw4Oaep2tkflQBXP0xTe9TSDLE44NRsBnmgBn40vbk0NwKMe5oAPxpuB0/SlGB2pce1AEJHNNI9qlPUmo2GBnpQBG3JqvLxnmrLAcHjIqtNxmgDwj9q85+H+n/wDYUj/9FTV8p19W/tYj/igNP/7Ckf8A6Kmr5SoA6b4YDPxL8JD/AKi9p/6OSv0PjUDAr88fhd/yUzwj/wBhe0/9HJX6Ir9KAJFFO9KQUvHpQAnag0vfoaaxoAQkAHmo2fimySdec1Vkn+XhSxPbvQA6aQ54PbqKpSclck5NZev+JLLRkU3kkalhnBfBxXG3XxUsXvY7bTo/tE7kKoLADJ6UAesWoKoOvTvXkPxH8W3a+IYtNsYjPBgCQrnhtxH+FLrPjzXbS7S2updPsYZFJ8xSWdeOnPGa8p0T+3/7Wm1w3TXdhHOwmkmc888kcYxQB6kt5cNBF88iqvzMFJ59qf4Q1AX+vHy2ZSrfMS3+fet6yt/7S0S3urIwMJo8lh0P5d6yfDfhmSy1dpHLk7sgIMfnQB63af6hOe3WvKPj7qGpwaJJa2Glfa7eSImSYg/uutep2WUtkDE7gO9cv8UtOudU8I3lvZ3At3cAO5XPydxQB89/CTToHhmmltytyOSygcDPr+Fanxre1XQLWKSRghkAOB6Z/wDr1zVlr1z8P9UltI2XUbdjhjnGOc+/rVT4n6+ms2ljPFBiz4YIX75PFAGD4iOjollBoNxMDKoErMcDOB7DvmsqKExRSTzPvkhYBY933q2dad9cS0u9K0H7FY26gF0UkE4GecexrHZLabVFWBpYizAFncFQfyoAv3+mCbQxqG0QtkYXueMmug8OiPXvDEOmRaGzzpLzdqvQZz1xUOuX+j6dpMWnQ7764ZMu+8bVYj2/lXZfDHSr37Lax6V4ksokmk3S2pRWYe3XOeKAPSr3SIfD+m6fa26sIioTdjvjv+tYWirfzeJcL5jIv3Sv3W4//XXsN9pNvf2scdwu7aBg980mkaHbWKqUjUMO+OaANHT0aKFQcngdat5A5JwKThV56AV4f8W/ihLp0l3o8dpc26Ou1bqOTDFvYenXvzQB7Dea1p1pIiXN7BGznChnAyfSn/bbZ3CrNGXYbgA3OK+SotZ8T6nZ2kjWsbxW4DLvyWbpg+5qzc+PtZg1C3uLuzeNolCgI7AEf/XoA+ri4x1p+evPNeAeEfjDfXF8/wDa8UEFgP4nbDjnse/Fe36RqVvqmnwXlnIskEyB0YNnIIoA0SOaMZPoKaHBOacf0+tADTUZHvmpT044pjdenFAEJ789ary5yeMdqtsMHpVaXqevFAHg/wC1iMfD7Tv+wpH/AOiZa+Ua+r/2sx/xb/Tj2/tSP/0VNXyhQB0/wu/5KZ4R/wCwvaf+jkr9ERnvX53fC7/kpnhH/sL2n/o5K/REHmgCQHkUuefpQOOaU0AITzioZ3KkZqbHFRvGWYZHHrQBSnJxuzjJrzTxr49WC5k0nQpYpdWkVlA67Tzj+Rr0HxNeDSdImuRE0xXoink818t+PdXtDq8a6FaSw67cnEk27G1ie3P1oAXxCpu7OceM9bCahACYkXGW7jgVjLd6R/wjkElkxTVixXdk5HPX8q5/xFo+oWOrQPrE3ns4V2O7cSPStrxhqWmajcabJomlmwRIypBUASNQBlX9pczywvdXLSFxwfWlkudV0fZpeoTSJps7CR0UDJUn17dKnvvs8cdn+/kW9CktCSeOv4dK3Agbwq+ua1Ak6cQxq53NwSBg+nWgD1D4V+JtKtL600HSp3mtZIw4Y5+VjjIyR6k/lXtMr21khkYqgIyWJr5F0XxWlnFZRaPpIt7xnG2XPYke1e82mr3N/Y24vMtIUGV7E0Ad9HqUU0avG25CeKdOq3cLQSniRcEe3rXLWEsyExgHCc7SeldNY3KlxHIBvHfHSgDzG7+FiWmp3t7YQfbFuCSYZWxtz75rhJ/hG8mmwyXWk6kt68zB4YXBVVycHODxjFfUMTDtj61IVGOlAHyhr2ia/o62+lTadNaeGS+0sF3sq99xH1NcpPoXhe48Tw2um6hMlqRlpZuhPpyBX2VqunwX9s0NxEjxsCCrDPWvMdV+Eej3V5A6W8cMaZJ8sYJ/UUAeA2E+jaLq+r2y6e1/I48qCQMSAT6Y4612Hw78LDQpItZnhl+1lmCq3AQEY/rXqUvw7sLBV+xafC5XG1jjcTjqc/54qea1nZRA8UYdWz8owOnoPw9qAJ9I8XSyyhZAoj3Yzgj6fSu6t7wPErqVIIrzO+sorVVWORQ4JY4HHHP9a6LQbi6uLaHLHyyo70AavjTVns/Dl5LbTRxTmMqkkjABCR159K+TNRs9Q1Px1Z2OpXyXuGQBl2jK9egPHevo34qaJqGs+FntNPOJW7g4HT+VfNOuaLd+GPEunzJfec52kyqeQckY/SgD3tbGxsoYkm/cwrAik7ioOMcfnj9K8d8f+LrGDVLm00GOOVQ3LNkjPfGevWqniTVfEHiTVU0vTZ5JCijhJNu7IB6mse8h0Kw0M2l5DLJ4lSU+bgnAGemc46UAYOnyrcX8X9rM8cLMMseMDPJr3/4Y+OLez1WLQbR/N0xVxDMeMnHQcc9TXket+INH1iTTYm0cW0cICy7CMt+WK6K2eHVNWgl8L2EltY2CqWIbaWO3/wCseaAPq6GUkAbhj0FWwxA5xj6VgeFroX+kWs/d0BPOe1baE9Mf/XoAmb9ab0PSl5wT3oJyf5UARt+NVpQcn3qyTzjFV5sH2HUc0AeD/tZf8k+07/sKx/8Aoqavk+vrL9rT/kn2ncY/4msf/omavk2gDp/hd/yUzwj/ANhe0/8ARyV+iQOMV+dvwu/5KZ4R/wCwvaf+jkr9EhzQA8dgAfwpR7ikzjkU8AHpQAA+mOKXP+RQcYGaMjsaAOS+IMmprpqDS1tS4bc/2hiARjtXyvpk1zq/jZ7m6tY0uElIxF90HJ/rX1X8QdCl13So4obyS02yb2dO4x0r5e8V27+HPFctzpEjPbqcuyZwxyc5/OgDu/iF4ROp6JDcxIPtduCwOeOM/e4+lcHNLc+OtAae4Fnp8uiqxUK+0zEjd0P0x+NereHPFGkX3hWSa8vYo5HifcJHBPJIwRnrXhHjW0hiJudLn2xSnDRxnA/zzQBWuL2SZDqE2kt9pH7vzv8Alm2BjIGOuB61o+HbK+8VWzaY0nl+UpkUOcDg5/rW5atrk/hbQtPsdC+1Z+dpEh3lhkkbvl4znqa6hfBGs6vrLXrWkmklUWNYYgQGGc9sev6UAc3Yx6prc2m6VZ6SE/syQRvdx87wDgnp7V7no+i+ZIgiWYiIDLNgZOOtbPg7wzbaXpsEckKCcIA7d2b1PvXWRxRq3yLj3FAHPLZG3G8IQ2Mds1Thhvnu1Kgqn8Qz19v1rsWhDcEcGnLAgyNoA9KAItOjZYQHzkVexwKSNQOlO/pQBG/TPpVN8MwGSBV1unOPzqqQBIeCAcUAPCgrg1T1C1RoiVXJ7Yq6vA64Hansm9SD6UAeW+ITNFI8cVu4eUYPPDf/AFulbngKxnisEa5diTk7c42n6V0V3pUM5zIoPc1ctrZYUAQAD2FAEnloyFSoIPBBrwX4p/DSGw0a/m0m3eZZ3V3kcgtAc8kYX7vH+e3vwOBjriqWorFNayRzqGidSGDDjHFAHxVZaVe6JHdanp2rWb3VtwYlk+bGMHg/WsCzuZEmuLww/a7+ctk7s7c9TjHPevRvH9l4e0rxN4ntJ7a6hup2V7VowfL5QE9/73+e1edaVpMyv9rnm8iANtO4kEigAdrVvK8u0ufPUfOS4bc30xwK0vDV/c6Z4gFrd3UllBMAsjI+NoIyP5iuivdD0awt2n0zWIZXdMnLAkHGfWuW8NGwudWuLjxBv+z7MLIQSN3AFAH0J4B+IfhrSFXRG1F5QD+7mfp0xg9PT9a9b03VLG/Xda3EUvvG4b+X8q+NPD3hG+vLoXssMn2MNlMqRvHUYr1v4evPp/iRFPnC1cHIDHnjpz9KAPoFgKifIqWE7olYk8jPNNYc8ZoAiYgE45qtMOep/wAOKssCQeevSq9xgdhj3oA8G/az/wCSfad1/wCQrH/6Jmr5Pr6y/a1H/FvtOI6f2rH/AOiZq+TaAOn+F3/JTPCP/YXtP/RyV+iAODX53/C7/kpnhL/sL2n/AKOSv0QFAEi46f1qVelRp2pJ5lhjLMQAPegB7yBRkmqv22Iz+WGBbrj2rlNY8WBLiS3t1G9f4gckfhXE6P4svLfXY47n975j5ZwegyeB/nvQB7UcOuCAR7ivPPHPghLjQb+PQbSBbmfc5yB8zH/JruNPvEuoEkjztNTySYU9elAHyLr/AIBXTLvTLW4tr4zTAeeYkyqc47A16D4e+FXl65Zz2dqJtJIAma5A/RTXtX2OC4mEksaMR0JA9a0o1WNQqjCjoBQBnaHodppFokFpEiKP7q475/rVyWDgbewqwGycUpHrQBRK8gnG70xUqNx7mpZIwx9qqy5HLcEfrQBaRuwp4Iqmk5BwFJ/rU6yFgBjk+9AFhc+tHQDmkRsjFKTwP896AI3Py4B5qm5KyFs8devSp5m2/Wqm/fn5SeOKALcTgqOcj61Kv4EVUh4bAORjpVtcgdOaAHcdD3pMHsaDQD2/rQAxhhcdKqXaCVSOMd6tysAp3H8u1UZZG3kA8dOfpQB4x8WvBWoazqsd5phQmADAcABiPfI54FeR+J7p9Q8TWum+LIV022iUK8sa9cDhuhzmvsCSyEsZycHGRwODXlfjvwbY3t6bi8sTcnjGOCef58+1AHz5d2vhWHxFbx2M90+nk7ZHcHrnH938a90+GngWdo7iPXLaF9DXbJZpIgJbvkjP16j8ulO0/wAKaEtpFK2gwx7G/wCWiD168ivUdEu/tNtsWMIgAUbSMelAHGeK9US2byYI4kijXCcYwAegHt6f/WrhNL1GL+2Eny8ig4A57nr9ef1r2LWvClpqku6YNkgDg9qqQ/D7SIwhUSLIpzuyP8KAOq0m4W4sYZEHyugIyOnFW2A55xVaytVtYViQnAGPrVnI7GgCCTjPU1Xk5xnp39auvjnNUbjbkgnjuPrQB4R+1oc/DvTv+wrH2/6YzV8m19Z/ta/8k804/wDUVjH/AJBmr5MoA6f4Xf8AJTPCX/YXtP8A0clfoeOue9fnh8L/APkpnhL/ALC9p/6OSv0OBAPc80AWFHArj/iZez2egSy2+7enPA9xXXoelcl8T7hI/Cl/ChjN3PGUhRmxlj6UAeKeG9a+13sv2u+jAcnzASM5+nU9K6+bwrJdS2xhDiAnLumORnt06/pXzp/Zt63iRrK9uhZyocu7NwvGR0/CvV/DHxAvdC0y+he8i1CKyGIsnDMAPegD3/w7Zrp9gkSEgABeai1TWEjYIo3OTggVxGgfFXStT0O3mulayuZhxG46kHBwR1qW21T7fMXjJA64x1Hrjr2HbtQB2EWqiNEZm+U9c+vvSL4gj+0NAqsZB0U5yaytPtftBDxODjqQMY5xnmremaDJFemSQiQ5yremc0AdVZS+cme/pVsEYHaq1nH5S4bBJ64qyOfegBDjGO1VrlQQM5x7Vax270yRQQecUAZU42ZIB3dOOpqS3csQPekuVIkwGzgdMHn2zTbNSmV8zPf8KANOIjH+eakPTmoI/lUZ4H6U8yrg8jHegBk8e5M4yRVKUgAliAeOauPcopxmsbU7ndG5QHIxx9f8igDWt84AzkY/wqyDjOMgVzmi67DLI1vJu8xcHkdvr7VviRWBO78aAHsRg54AFQTTBQQCN3YVFdSMo+TPucdKpvP8wQg7vfr0oAWa53uI2Ygmp4YSWBOR7E81Q8ovNvC4GP581sxoVQDIIoAMfLj265rP1O3SUfOwCj7xHXFaUzFVIxXN+Ir9ra1Z+RjBP0PfigCG6sYmGBhkzgf59P8ACrGlRJbOFjzyOTjg1meH7pr+3+QHbnqcf/qrpvswjQbckjuOpoAlifJG3nP6daS5uordCZJFGBwCetcR8QPGtl4Q0xnupD9ol4jRDk5Pf6V88+MfHuqR+JjPpms3F4WiCsjH5FJzwB0//X9aAPpgfEHw59lFy2oRLbl9gkYELnj2966Kzv7a9hSa1mSaJwCrK2QQa+J9/iBdMWG4j3Wjv5xjOOc4PT8a7Tw3431SbV9MtLG4fTxbgqyuco/A6+nSgD6sLZAzk/Sqs2CxyfyNc74W8X2Gs3M1gkxa/gGZV24H4frXRTdemR60AeD/ALWox8PdOB4zqsZ/8gzV8m19a/tb/wDJO9O4P/IWj/8ARM1fJVAHTfDD/kpXhL/sL2n/AKOSv0KLZ4Hp2Nfnr8MP+SleE/8AsL2n/o5K/QtEoAwvGXiyDwzpjXMsRkfgKucAn6/hXy/478ZnX5572/e4j1JTi0RJP3cQz/P/AOtXsH7R9he3fh60TSlkaVZN7omSSv0Hua+fdS1TRrjwotqLF01uI4dyOTjHPX2PagDBREvbmWbVLmRHbnfnOTWpaaDG1wFtJmuyV3LsPXrx09qx7ZIpIglzOI9wyCRmrWkXTWvn3MN35b23ygf3xk9O1AG5pyyeItYt9Kvpl0/7CrBXJxlh2PocD9K9F8Ia/Jd3ctsSsps2CCSBvlcZ4P6frXmXhODS9W1p5tVumhaTLFi2Ofrmux8DW2kWHjGaxsLqSaO4ICOvIHXg880AfS3g2APpsUzMx3Z4br1PWukQBMHAzWRoYW2sIow+4AHnOe+eKkmu8FefvKWx1OKANYMCc/pSiTpWR/aChcbgWAweehpVvgWAJ4Pv6etAGwGB9cUrEYrNjvlAG7I5xyatRzo2OefrQASxgg8DkY5FUgvlSbcNs6/Sp7i/gjm8ppFDkZx3x/nNUrm6d2JjUkccj+tAGikgb5lHtTZMKm7v2qpZPLgB1/HNSSXALhAfmx+tAFUqxkLgHcM5BzirEVuJI8yJ8xznNWI0A64zxkVPzjnkkc0ActeWot795o4yWJXPAx/nrWlaXW6NUjHI6qSM9aTWVIZWVlGe2etZttcKtyiMhOcEN2xmgDcZXkjDDIYj1z/n/wDXUHMUjDgseACMDtVqGXJCke+DVgRKQCQMigCraQnZ8wIHoa0EAx060IAoOKd7CgAZc9uaw9c0a31WHy5hJgkHKkA1un1/lUQUHj+VAGRo+kxadbrGmSBjBOM9OvTrWkyBkx6fpT2HTFJJgIc4zQB80/HG/wBOuNRvLeTTbq5ulTyoZjkJG5Y8dP8A9dcV4HtdK0e9261+6u3Q8sAAvy46/hn8a2vjrcaxcavPbwAeT57OscXLN3B6ZrzXQrK+8Sa8lrf3ptmZSTJNwRge+KAPXhdaDJM891fxLGwyqiQdPTn9cVzfinStHlsGuNKu1c53fK68fSuWh8GJJb6vI2v2h+wsVRFbJlwM8c/h3rnv7O1ZLB7mOK5+xp95xnbjOP50Aem/CLxPHpWoC4j0q7u7pJVVpkbICMCDnj3zX1duDKrbSCwBr46+FDa7YwzXmk2guIZpkjYEdx36ehP+ev1+rFbRCwwQoyfw5oA8R/a2Ofh1pvX/AJCsfP8A2xmr5Lr6x/aykD/DzTxxn+1Y8+v+pmr5OoA6f4X/APJS/CX/AGF7T/0clfocowea/PH4X/8AJS/CX/YXtP8A0clfoeAMGgD59/aG1u7sNVhuNK1ACWGMQvCO2cnPX0IrwnwvrP8AZeoXNze2IummU5aQcrnOT0969T/aAtbJNdkmgeYXAkXzlL7lOVyOO3FaXh3wtoniPQmS5tzAzRjEkJ5HHc9/XPtQB5ZJ4buv7JPiOySKVJZDtgIDEZOOlZc8Wpzz21hcaaLc3bAIPK2FsnGa9evPhVdx2bW2l63diOPLJG4+UDPIIHvzXA+ObbxCl5bC8lzPp8YiV41x909c9zQBq6Hp2i+F7q6ste4vZIwItyZAbGcj+Ven/BzwmzQLd6hp6od+Y324yuOvrXFfCrwrJ4w1ezvPE9pczMgLebJna6gYAIx7CvqmysobWMJBGERRgKB0xQBXFpti2Rjbnrjoay7izmwzqMnBA4710pRfX8qGjXrtH5UAcOiTG5dZIXwg4JOMY6f4VprEscTnnpkDHBB759OnH/1zXQNaQsSSuGPU1Wu7NGiZdpPHQUAczcG585WgLbepCnj8Kilum85jLOsXl/w5yefXmr2ss1rp0hhVyUU/dxk4Ga8v1DUFEl1NffaIFhTcxJySM5IHGPWgDY8V39ppF3BeXOp+UUHy7m2hiBkAD6is+/8Aidc2en297DYpcWjyBDMrnjnGen0/KvJdf8RaL4j1W4XU01BbOJSsLLIAA38vxqx4O0XU/EWmJp81/MNNDnyoY13Nuz1JoA9d1L4h6xBqVhDZ6VHcQ3I5VZMsmcEdO34V1HhnxXbavfyW0rJFdQk5jLcg49K8Zn8D65ok63Wm6rKZ1HyrOpbao5GOOOntXG/8JR/Ysq3dqt1L4gWVhcTmQmNuTngUAfZ0TKAMY9iKc8ojBLnpz+teWaF44kHhC21O/KvI8Yd0U7cnB7/5/pXD+KPjNqc1k8ej6PO3mAosjPnkgcABe3NAHpPxD8aadpQCG4iM6jDRq3zYHX3H4VzOh+NLHxHcGK0uVhlGUzu2kdACB+NeIalBaahps+ra/qGowa5JJzbYB3AjI+U4IHarF7faE4sk0+2v9LbAEtwjfMR3P1P+fSgD3m68Vy6LNFFA326RSFZVznoMnv616DoviGy1K1R4ZkZ9o3qDypx0NfImqaXenV/O8JajfXsWMv5kxZ8e5HHY16B8FPtl7Nd3ImnigjkZTb7skHAyScZPJoA+lEkGDkineco68VzsF4ISY8N0BOT0FWEvWkPyrjn73XFAG35menemlsGsp7hwOcb8BvvdRU3ngx5B59Twf/rUAXGde/XNY+va3Dp1pLLIwJT+EAnNEkshKn5mJ/hz+v8A+qsLxlBPcaRMsKhH7BgMUAfNV9FqOveINX8UJchTYSlxCCclQSfXPTr+NcRf3a+I9eea5uBbB16kFgMDgV1+n6Ws1jr0uoeITYXQZ1e1Vgok56Efj/npXOaF4fttRL/Y74G6QFlR04YZ56H0oAx7myT530szzwoBvlK47e3Srmk6veeR/ZMt9JDp05AkyThe/T60RWuoRzy21uPLIyJEViAfXiqOpRvaOIZECtnJIOeaAO500XvgzxNpMGm6sbmwuJEldUf5Dk4IIB9K+sDdm4iTyzkFMgjnjFfNvgLwhZ67q2kx6XetcIqpJd7hzGfQenfrX059iSKNIh0QAAZ7AUAeHftUf8k407vnVYv/AETNXyrX1f8AtYqq/DzTgF2n+1Y//RM1fKFAHT/C/wD5KX4S/wCwvaf+jkr9EVGeDX53fC//AJKX4S/7C9p/6OSv0RiHGf0oA8k+Ofh9721h+xaW13JdHa0ikkow6V5Xo2tzeG5jp2rho9uMH2HH9K+sLi3S4i2SDj+VeY3PwxRpr03Qg1HziTG04O6PPb/6/FAHIQ/E7R4Lb91cxFkI3hs4PTPbrivNtf8AE7eM/F0KyXiaZp8i4aUplQQSc8+2BXo7fBBJrK5H2dIbsyM0ZEnyken+cVsaR8JbeS209detrdXtRtMcJyrDJ6nAJNAHS/CTQLjSrJpH1Zb/AE90AtQsYBUepYdc16PkDis7RrO206witbOJYbeJQqIvQAU281a3tm2yvjrjg80AaowenNO+uKo2N4lwgKHPXn8atsSUIDYyOo6j86AHqAAOc4pGHGP60uRjmmk8jGfrigClexI8LBwSO/NeLfE7RbN9GvpYp5IgsbEk88j9f8/l7jNhsH0GRXDeINLi1LfbzpE6TA/KwGMHIz/n1oA+YlvtTbwNBFDoPn6dEzgXflt8/wAzZJPbH9K9n+DskTaDbyQ2McLhmDKzZPXORntzWT4i8Ka9bMnh2xuLe30CVTIJAgARiSWH5nPWuD0bxHqHgO+uIJ0e/tYiQJFbCnODxkfSgD6N1OWL7Hdu4RCiMSzH2OT/AJ9K+XoPFN/pdtqktvocdxbXE7lbp0OFJOO3Hat3xX8Tr/XdOiXTbK5t45Bskmd+MEYwOOeBWzoPgfxNqNpDpGlXlnN4ekTzzdSLwGJztAPJ5xz70AavhHw/Lq3gaKW7cpM6bhDgALnOML+I/L2rzmC78S22tHRbS1SWWNtyB4xkjGQeuDxn86+jrHwpc6bZwWxuNwjADPjBJAIHOeOpP5V5R408LeIm8c276RcJbxOCPOOAR6jHU9OB/LmgB/w88Oy+IvEF3rPi23UT25WGNE4GV46D8K9Mu/C2kagoYQYUruRgenHUc8Yrj/hNdR6XcazpOpXUc97DNuaTGAWb0r06Sa3SMOJlAUkgA8dutAHhnivw5eeA7oXukXaxWszFZAwDDHHY9+a6r4Xy6fa6vJbWWqJqRu1+0SOWBYMQM/h2rn/ih4ih8WXQ0fTLWW7itpN1zKoACr/Q4zXW/CzRdOXWnvNIs/KszCFDNktuwAeSc96APTZAA2UHI6f7QP8A9akggZc4XAI6HFaYhR1OU/MZzUohA44x34oAyTa7jwhyQMk5q1FbL5SAliV5y1XPKGOeo5pDxjOcDtQBVaAbgefl6VieLpBHYEMSqr1A7+3H1z/9atq5u0h5kAA5x78VxHi6ee+dliHEXPP65/z60AfNPizSIrbxVJf3EEs1g0hZ0XOW5ORmscWsWueIc+F7drVETOxmz7Hr9a+g5IbYXJW8txJGckIFyT09f/rVW8NfDGxutbl1C2P2SF12mOMkE56jg4GKAPnjUrLW7otqBtLj7Pny/PCEIcYHX8RV+88NHQ9PsdS1S5ieWc7ktcgkjrkkHp/jX0ZP8Jyvh+XR5NbkFrIxbdsJOMg4688gV5z4y+E0em2fnx6jJceXwqyA8jgcHP1oA7L9nbV7DUTqsqafBY3DMgzG3+sGD+Ve1y5zx685r5R+GEk2heKIYomkjQsBKoyd3Br6thPmQo46MoNAHhP7W4x8PdO4/wCYrH3/AOmM1fJdfWv7W/Hw704Y/wCYrH/6Jmr5KoA6f4X/APJTPCX/AGF7T/0clfojH9a/O74X/wDJS/CX/YXtP/RyV+iEfrmgCYtgdajMyg4PX0okIEZ6gV5lr3ie+tNTkNsrvFGDu+bOeTj6fnQB6duXAIFQzHK9CRXCaL4z+3COOZCjnhs44/Driu23s8GVOMjpQBEblFjkGT8vUCuM8R2t1ezrNbDBTJIJ4I9AQOfr71d1O+W1v3TeV3vz2C8frU1tf+de+QwKNn65Gfyz/hQBP4dt57C2j88FcZBCkkfeP+eveupjlyOTz9aqxJ+6AHTpT5ZBFwfvdvegCaSYJ16e1VZLwAp8pOSOhz1zVW9uQVUDO5hxg9faqiJIxQqcZUFT2PXj8sc0AajXIPA6HtnrWd9hjuJZJow4bOPmPHtipoFaRnV0ORxnp3rUtY1VMDvnrQBlXOnx3mmyWd1F8sild3cZBGf614z4z8Jazo/he60nRLeO+gkIcyzH96ck56ADgmvoDYODioJrOGY5dQe+cUAfKKadreo+HoNK1HTpLGGIcyRjBlHoBj3Fe0fDCWLQvDMGmpDIqQsQvnHDYPOTxzzn866PV9JiL/KsaqDnlOvbr+NZ9pY+dfhAQF2kOF4DYOM4+ooA6iCeO7jAQbge9c74q8Ex+IbBojc3FrIFIV4HAYHt29v510um2QtYgqkkdQD/ACrRP3cf0oA+b9f+Gb2N1YWkFnqTSNt8/ULeQHd0B3HHHf16UX/g6Ww1y1tPtHiCaxfaGmU5APPBwPrX0XOAeuPeqU00asMgHHpzxQB5d4N8Ealoep3y20VtDpc5GTMd0rDnuAB37/8A6vSbO0jsYEitUURqMfJgDn2FWUkRyRuBI657cf8A16dIVjHuOMdKAJISwA3YyT2I4qypBGR0zjnisyO6BcqwypOMGtFGG0Hv64oAkPXPT6mq74/hfocZyOKlJB4pigjeWP3jnA7e1AHFeKJJrRiTnYBlfrzjH6Vg2F48ru1xEyCRsAjPcdf616RfWguEVSAwHTIzis46HAqoFVdiD5Ux09cUAc0dNhvJlZDvZSAMnjA9B2/z+PSaTp6W7lgRx/CuAOe/H0pq2sVptVAgC8HjGK1LXDJkseOPSgDhfG+sNbTGMyFIlH7z0Pt/P8j6VwT+IHv28sqnkDI3b+/Qfy//AF5r1rxB4bt9SMrSxo5Zcd/x/lXBaP4Al/tqVro/uIjmNcH0OP5/oKALfh/wJA91HfPlSWySuBkc89K9OSMRxBMEBRgYNJZW0cEKqgAVRgY4qeTj2FAHgf7XRB+HumYGP+JpHx/2xmr5Jr63/a7I/wCFe6aBnnVYzz/1xmr5IoA6f4X/APJS/CX/AGF7T/0clfoenGBmvzw+F/8AyUvwl/2F7T/0clfoch5oAbfPst2Y9Aprx7WBFda8rriMs5GCR0z6V65qkLXNlJHGSHYcGvm3xhd6joOotNfx3BMWWTcuFPOBz+dAHplroHnTRvGuSDjzF4/zz610GqeL9C8PBLPVNThhumjDRxu/zMOQMD6ivnzSPiZ4o1W/GnWs8FhFtJExTcVAHvXDeJPEN1qGq28WpeXdXdm5jF03VxuJANAHr+v+P9GvfElxaLMII0ORK3AIxVs+K7cTW66Tci6ckBjG2/P+RnrXh+tajFLrcd1rOmxyQlQGFsxj3ALgc1Z0hL2PUm1jwxbSJZW58wwyMXwByQeOmMUAfZeg6ml1pcEu5fmDZ9jkiprku8XDqxwe+cn/AD/OvLfhZ44i8UWn2eK2W2uoRlkDZGMnp/nvXrFnEGg5zzgUAZ6hnl8sLuf9MVuR2YGCeDjHSpILeNCWCKC2MkDrVkcLx3/SgCGOELkgZ59KlVQBgDinAgYwDQQAOfpxQApHQ03qKGYKPTjrVaS4QRuenYc0Ac14y1R7CBSke9ixIw2KPC10t9Ak7blZh905POc5H51Z1XSYNZz5yvgc4J4ycin2VsumFYkjwmMDaAMHPp70Ab+eA3f1qrLfJHKI8EsecVVlvsEbEYgA5I9v8/pUMFoZ2SWVmBXlTnBoAt3N2rYQEZIyP/1/jVa1O98BMnrnscDvVmaxiZkYjkAcVLDbJEwZOBjpQBII8Jxj0rM1BMyqSTj7pwcYrZCjbjn6GqF3BvJyDj2oAyYwImHmctk8n1/KtO1u45PusOeh6Z+lUHiCsscSsExycZ/D/JqJ45YWLL/CuSM/jz780AdAsqnpjmpPQVnWs4CAfd4HA+lXlk34AGR60APKAtk1G+FAz09fSlMihfm/nXj3xq+ID6VbT6XpN29rfptYyBQ2VxuIH4d/rQBd8R/FTQNN1g2CTfaLrJRo0UnDAkY4HrmprL4q6SusJpVzDNDcsPkGxyDxn0+tfMt/faxr+pW15b2sMEyjAlijwWPqT3roL7QvF1jdW+tz3hkuV4WQJnHUYxj60AfW1lq9jfTPDbXUMk8eBJEGBZD7jqOKvJEAxOwbjzkV8j+DfG2q+HdfuHubKe81e+dQHMhRc9BkYx/+uvqXwpf3Wo6NbTajCsN6yAyxq2QCf8igDWwAOAMVHIMH1qc8GoJu+BQB4F+11/yT7Teh/wCJpH/6Kmr5Kr6z/a5P/FA6YP8AqKJ/6Klr5MoA6b4Yf8lL8Jf9he0/9HJX6GIwBI96/PP4Y/8AJSvCf/YXtP8A0clfoPzn14oAtqwI/SsbxZoFj4h0e5sb9C0ciHkcEH1FXw5HP8qa0zAHaCSc96APjHx9oGk6C9wunahNLcRzGF0btgnPYegrjFNvFDGxVpnc7mOcbTmvdvivHZWWr3mjtpMU0t84milUYIdsnk/X+deJ6lBJpk62V7blChy6ZHIz1B/OgCyNW1A2Bs57ZZbUDKA9Vx3z+NN8L3V5carHYWl2LSK4JRs4IOR3Bpsosp5TfQS/ZbZAB9ndyzMcYOPbNHhd9K/tVm1pZLe0kBKugJKnHtQB6t8HNFvbPxjeWEVxE/kIrmaM54LY2nHTvX1FYQLFEOScnOSc18xfAS6stL8Szm3vTexXrLGuVIZSG6nOeOf5V9TJjoDxQA4DJo3460Z44/lUXmDoCCTQBNu57EUEkngkVCr4baPftTZWwrMDz7UANmlywXoScd6yZ5mL5OCAQcAdR7GkvLobmY5O3jjtT7EGZFZ+QTnB/nQBo2iqUVhxnnFSyQB1wRREORirA5APegCqlqIwSOnXAPSmMQjgDHbj0q6QD2qndrkryV+lAEct0pZVbGOPXBp6tkcDHWqbERuQoySuCfU+lTWuOOpA4APagDQUgeuKZIoJ7celKijsQfXilfsOlAEJjDHJ6fyqpcwbgVUNhuetXWZVBz6VCzKWwcfT1oAzzblGLA9B/nP+f/rU7zVI7OFpZnjREAzlsZrYu5VigZmyFAJP0rxX4vayseh3nmu8fz4TDc9cfX/DP0oAr+JvjBc296LLRbWO9mkzt25yOo9PWvEPEp1bW4b/AFHXJVju0dSYnAVmzxwPpj8KGtrzS7O31i3vg9w/CKPvAY9/881iSPd6jcyxahdGJv8AWEy5AJx/hQBp6dda3pVpBeSWcoskwVdlIBHHf/PWva/DfiGPX/DcM/mRibODHtyQRwcEcjOcn/OPE4dV1R9PttL1OZn0csASADtXIzg9ew4zTrq7XQtWH/CPXztagA55A9wQaAOv+IM99aa1BLCI7cxhJM4yN3Bx9OnHvXunwgur+5jF7qWpQ3DXcCskKIq+WB9Ofzr528Z+JI/FNxp/kRDzHVVfaOQeB6V7x8F/D9jYtHdWWoTXLJbiORCG2oxwSRnp0/GgD2FjmoJzyc4p2/HT/wDVVedxnjqaAPBv2ucjwHpgJz/xM07/APTKWvk6vq79rcn/AIQbSew/tFeP+2UlfKNAHTfDH/kpXhP/ALC9p/6OSv0JwMcjj61+e3wx/wCSleE/+wvaf+jkr9CFx+FACkAEDGD2prKDkDofWpB26/nTS3AIBH9KAPJvi/4ea4mtdRtJI7e5jYDzZcbVyD1wM/59K8Q8U3Vrb6vfW/jMfb714F+zXFm3Cjc3BLD1zzzX1D4/0MeIfDtxZxuI5GAIfGcc18zePPC1ja+JLCG81IzF7cCR8kneCwPU8dBQBx1sPDX9mSeeupPqKyARxoy7WXJz/D6Y/Gug1GDV/GC6fEdG+wW9qpTcgK5XucH2Feh+CPCXhyyEFzJDFNPH8wkfDZ69Ae/+FdDr+r6fpts/lhLaNUblsAOccY9e/wD9egDyTwhLdaLrc1l4ZQXEzRq8kkr4KEHsRjI5H/16+wPD979s0i3nb5mZRuIORn+or4p0HRdY1y/v77Q5WiQDDMrEEg8Y4ye1fWPgewuNA8KWlpdXDSyRjLu569+/QUAdDr+rpplm87pIwGCdoz+ftXL6V4pbULxAiJjB4zgjkc/rV3XXF5p8kcqB49wBXr3H+ArD0OyFvOBFHGI3BYMFOQc+30oA9DtbkSRhgAFxkHOevakmkOCFB/Cqdg+2IZJYgAE+vPNWZXzlcgjuR1FAGVNbCSdGBYgAA4OeK0NPXcUyjAAkhiPao0O5izBVOCee4/8A1VftSNgCrgDgcUAW4wAF6jHHNPwM8H2qPONo5/KnBgQMdx2oAdkcYJHNVrpgqAkVIzqDjuOM4pjnLY6+vvQBiXcw85gUGcAc44/T61Zs5QXCrk+p9abexD5Ru2ow6ev/ANfmn6egCqOMLnH1/wAmgDSDZxxj8aVgPvEkcVGow/B4xyvHJz1qVjkEDOPSgDD1fV4rGJhLlRjvxj6VjW/iS3nOV/nwePfFXfE2knUNixsVYZ6D1H6da5TT9Ie3uwjEvFgnJ6k5Hv06/wCcUAaPie8uZLdigzkfId2ARx1PbH49a8J+K6Tz6Uk80jtF5v7whs/iP0/OvbfEVxFHayx7CWWPgBc54HFcBq3h2+8S6Jd2VnAFa4bfl8nbzk/yoA8Q1f8AsuDULNdCvbmW3cDf555Q/gBVfW7K3j1WeGBZHtVVWEpPJyoPp6mut8Q6dpeiw2+h22mSza4GBEu0kOTgfjyOBjvXG3V/LDfzJqELhuA0Z4wccUAR3As2sUFs10sn8aMQVNbFres3gaexTRGlIl3fbsfdweRnHv69656GQvPst0JaRsImPX0r0SwXXLK0bw+ul+b9pU8rHg9QeuOcevbNAFrwD4XFpfaU4sn1Q30as4QgiDcO/Hv0NfTXhDQrTQdNMVlCYvMO9lYjIPXHH1Nc18IvCb+G9BiS/ZZbt8NkgfIMD5R9Oea9E3ZwVAznPFACMQDnBI9f61G/JBJODzTlJJyDnP41E455J980AeDftcHPgnSc/wDQRH/oqSvlKvqv9rkg+C9H5P8AyEPT/pm9fKlAHTfDH/kpXhP/ALC1p/6OSv0HXB5B5r8+Phj/AMlJ8J/9ha0/9HJX6EDpQA8H1z9Ka3JJOMH1p4yeMfWlIGAcd+9AEQ+9jHXvXmHxO8E2s1rLeW1oHuZHyZAgJQkjmvVVAz939akIVwQy5HTkUAfJVxbeKtK1mOCG3a8O0lSox8v3s9eOP8KxtU0nxP4jgkkmtyLaBjvUEAjnnivrW68MaZcX63xiZLgLt3I2Mj3FRaV4Q0rTZLh4Y3c3Db3EjbgT9KAPOfhV8NrXTFh1Ox1G9+xzRhjC3ALA9x+Fesy2qMgXHyjkk1YjS3tYhHEiQxqOFUAAD2FZl5rdnbsQ0idP7woAydatYra2LdUHJ+bGTn2rlJ/EQhaO1RGibAKgE5PXgf8A1q70yW9+rxbs47FgcV5x8Triw8I266r9iNwV4EXQHk8n0AyKAGyeMXtLloxFJJufAUAnkegGfSuq0TxCuoWnmEiN2PAY5A4Hf8a+dJ/F2s+JI72+0iO0tUt/3kiv8zEfXGO1TWnjDxNZ+Gm1KVbV7fpwSGHbpjHc8UAfTlvcGVVAMjIeOe4/pW1bsBGPfnivE/hV8Q4/EcMdrdJtuUGX+fjj0717HbzM0YJXIHPX/wCtQBe3v1GP/r1Bc3KxqNx69Oepo3EqwIIxxmuW8TXkgRo4nkj7Daew5/pQBvw6lG8uwcOv3snArQWQENg8CvLNI1mVLorJAwCkDIbkkZH512NprUZiXcCGx0J/rQBtXXzbQSAcZ7VBbuFIXzF3dTz/AJ/l2rEv/E9nBMA8hy2PmVhx/wDX9q47X/iLY6VdLG8gDMQcNMoHf+v+e1AHrSzKF5OOwqTeM89fSvNNH+Imj3R2SXcYbAOTKOOfY/SrGr/FHQdMuFtjL58rAf6pgc5GfWgD0KQKynJPNc9rLLDG5XkgY57156vxia7v7uxtdAuw8ALKzSD5sHHTH0qv4S+Kmm+KNQWwv7WS0uSxHLgrj0HHX8KAOqOhtffvbiTYGOeACW74P8q39H0u3tLcKxXA+X2P61oWVnAYkI+bjKnHtWN4re5hspRbylDjOc8igCnrtnomoXKzzrbC+X5Y5sLuHPGD/Svmv4iwDwxqmoWN9p0eoy3BRku5lwQNoP59q62HxDetfy/aLa4k8t8rI3fnjqOn51J8QVutY0qG48iGSUso2P8ANgY5PA+n4UAcr8MtBPjC2bTbPTVt2UgvqO3d5ffjp2Hr3r6U8NeDrTQ7dBK7XdwvWeYAt2/Lp/nNcV8CNBuNIF4zwmFJmVsDOMbc8Z+teyMilPf8qAKxwHyT+gpep7dOcDipPLGeQeMd6aQQeST+NADM8kDtzTJB0PPXoal46fTvUMuDkkY/THFAHgP7XXHhDR8dDqHH/ftq+Va+p/2ujjwnoi4x/px6n/pm1fLFAHTfDL/kpPhP/sLWn/o5K/QUZ/8A11+fXwx/5KT4T/7C1p/6OSv0FBHvQBODgjPT2pRz9PWmDBHB7fnThyOvI9KAHgfgKdnA9qYD7cEZpQenOKAJEOcZzTjn1wfpTA3IHfvT89iDQByHxEkuIdFka0QtJtIO373IPT9a+exf648qqWHk58sjbgj8T7elfVOpWy3EBRlXB9a8T8XW66Zcqstl8mSweN+D+H5flQBr/Dya9igcXMrCNU4cnhh1+vHNeYfFzxZqkOsJJHeWN3ZSRtCIFCkA7m68knFL4k8fGy0lrXTg8bn93uUjKD16d/8APt5X4mtYYrq3aC+a686NZWJzlWJORQBLp2jXN9JLi5ito5F3kE4B9v1rKubqS3BtRKXjRjwDwef/AK1PnkaLEQuJAcYyOAM0kCgK0UsKMMEhiOenXNAG1bXWqAWl/odjJawwKA0qfMrMOpOfxr3T4d/FW7u7hoNaW3S3t4y0k6HAH5A/5FfPkc2up4ZYQyyrpDybSqkYz834461Tspp7SCZ4bhhuXDqM8j0NAH3jpmrWOs6eL3TLqKe3l+6yng44PUeorJ1i3hncFixC5PynGP5c+1fM/gr4lnw1pNpZ2YuHzJmZCflX5v4ee/4V79cLc6jBazRuT5yKw+bnGc/1xQBkX6mC6M0EC8nHyuCT+Oen5fjVe/v7k2+3zI41HUkjJB7Zz/nFdFNpciIg37sDGR06fXp1/wA8Vj3vha5v5/NdtyoeVXPUeh/HFAHmnxB12bw1NbtZFbmW5Qli/Pb/AOvXl8XlazHc3Osah5EyD5ARnOMYFdN411GWx8a3Lz2TzW1h+5xIMjcRkE5Hr/KuQt7WfUzdai8QFqh+fbgBSenFACW500aVPveRr8kCPBwMc89Pp+dGpyXOmeVZiaNmCrIXQg4JGcZHpms6KFDlnmWMfw5GTVuwWxxc/wBpPJ5gT93tBOW4xmgDdhXWJ41urG6nluJBlvL6/j+dSaTrGreFFlWWxjEkw+V5lO5T2IOa0vhFexwz3v2kNIFTKL/M4+laPxOs57pJbhotipyGz1wef54oA+kPhTrUmqeEtLF7LE16LaPeEIyRtHJGeO1dFrdsJ7VlAyfpXhX7PE2m2ksCJqc899coN8DbtqYXoBnHB+nSvohlDrg898CgDw1vAeoy6qo8wwRb937tRj1r0eDwbazxRpeKzJHjaufTpn9a6lbdFYMEGfapuAM0AV7Kzhs4VjgQIqjHA7VMRjkkUrsBzUTuM9eSKAFYkHHU9qjODjKnuOD1obJPTHHXNN5xjjj+dACHJOO3rUTDBAYc4qQ4GQB059vpUMmBn7oJ6f5/z0oA+fv2uif+EX0McY+2t/6Aa+Wq+ov2uiP+Eb0Ic/8AH2/t/Ae1fLtAHTfDL/kpPhPP/QWtP/RyV+goK5yASP5V+fPwy/5KR4U/7C1p/wCjkr9BFbOM/nQBOG5H0zzQfx5H40wHPXPIp2aAHg8/TrTuO/5VGDwcdelKevtQA8sAcdKeG75/+vUIPXpQvIyMcUAWhhuvP41y3ivwnBrkRxNJDIP7pGG+oxXRK/TOelDSgHmgD588QfBO+uxcTW11B5rMNqsMBh69ODXl3jLwZJot5DYWsFzJqwTzJYiMrjJ5Xjpx6mvse7vFj3ducf8A1q81+JGgvqlympWB8q9jQRlwpzgFuCPTn9KAPk27L27stzCwuFOGDDlSKmD3+pozLDI8SKEd1Q4RfeuruJ5dEudQi1bSY76Sb5Y5ZRwrevI5rLutT8Q+GtNn026txb296u8Boh8w9jigCnrcsdlb2WnaPqElxbSQq8qE/clOdy9BxXbeEdAFvYGC6iUrcod28YKj6Ee1ZXw/8PQSW39t3yR3IOfLhJxtYN1P5frXT6t4g+yJJLKsfmCNgqqRjpgf19OnfigDi9NuLXw74vuYTpa6rbltqQkjrxg/dP06V9b+BLc3Pg/SpZ7c28rQh/JbBMY7DOPTFfLXgXw3rniDWpdZ0nyMxSb/AN4D1zn0PpX2FpUclppFnFPgyrGocquAT9O1AEUqQQDMgAXuc9PxqnbatpxcRRyISOWCnv8A5/nXPfEXWPsNk7ecE25JGR/d9/8AP615boOuXF5qSvbvKXVu5yADn/69AGX8fLvVIdS1CGVrVdNkmQpGrHzGwg5Pb/IryRtQeWxNta7oYD99FblvrXpfxrlsH8YabLqMsrwSQhpY4z0OcevevKbsxJfTGwVzbg/Lkc496AEhtkaNnnYog+6M8mtTw6rvefam0w38SIwMKnjpjceD7VkiO4uBnawXPpgZrfkttb0CaKxsrjMl7AshSHng84PuMUAN8GagNO8QGaNCY3yPLHJA3A/pitzx34gkv5FsonDsSEGwkj2H/wCquVsNI1JdRkhiQrcR53Y+uK3fCfhubXpzHC7PqO87OpHGOT3oA9j+APh+MXNvPLpEkM9ugka5fG1iV/hOPQn86+hEbHrx2rmfBGk/2P4c062mMbXa28YmZf4n2jP610Klenr60ATlgeD1pruADjJ47VGX5AqKRywIHOBk/WgB7tk8/hzSZH05wKjwAQM985z2oz8u3qOlAEhKjjGOOn4UjEdevrz0qPJHQD/Gm7h1AHA656UAOLcZBPXJOcVFIcdeQQDgGlyp+7x2JPrVeR8kjJweme1AHz/+104OgeHwAB/pUh/8cFfMNfTH7WzZ0Xw+Mgn7TKc/8BFfM9AHS/DP/ko/hT/sLWn/AKOSv0ADDgg547V+f3w1OPiL4VP/AFFbX/0ctfe/njOG4OfXvQBe3DIBxTt4ySeff/61UftA4OCAOeop/nAhhwPxwBQBcVsjdg/40b8ADgjiqnnjpzzxkjml8/GOvXg5oAt7sDnmkR8k8+4qoZwef607zu54BH+cfnQBZZ2PQnOKgnYsuGGRnFRNPyOo6GmGVSR14xQBWnR3b52BXdkYHpUTRIQzOp3EfeYY4/8A11ZkZXHzcBe5qOR1VCMckdcdKAMLxFollq0Bint1fccFwoJ9jznmvCPEXhR9L1iVdb8+70hQxicsf3f06+1fRZIDEspyOpzxzmqd5b214xS6t1kDD5uOvP8An/JoA+W7Hw9cywaje6TfhLVSVWPfglcng9MdM81c0fwXLNZ2OqXMsl3GZRvt4l35APPQn8eK+jrfwl4eSBkj0yFUk++AcA/Ufia2NG0fSdKgWLTrSKGMMcKOR+dAHK+BPAMGn3MepxpNZh0RxbDgAg9x6/lXoWpMy2rFByB+XBoS5UpgjC4/KkknSRSDkn64oA8M+IVpcapqqgxXMcatnK87v8/1qhpdj/ZFjI4il8zZxjHQMO31r3O4s7adg0iDr1xk1har4btbuNljaSIOvzbSDu4xzxz0oA+WfEkF54i1QeWqvcMcIoJJx0HWvQ/C/wAKPENnoFx++t4p7hOQ8YcqPY59MivTdH8AaPpOofbRG8lwcfM7Z5znPvXQ3+pCKLCkgZ5oA+dLzwR4pbTP7OuLdI1hbgKR8/X0OO9Z2kfDfxT9uS5XdFJGCAWbnGCPWvfJL5nKsqZYnoc8fp9P0qyLg7QN53AYJHVun+H86APGvDnws1ZdWa61K5ZUb7xVuoPXPPua9g8G+EdL8MLnT0Bnc/NMy/Nj/OOlWYJB5WQ+Sxzwee3+FaUD5TGcjPGWzxQBsLMVII+YYH1zjNWBKFXBPHXisgXHTAJ4xz9Kd9rQKQfbHzUAa/nA7TjjqD+PSkaThgWwD29aymvFyqkg56ZpGvVHYc9DnNAGuJuRg/TmkEnuQO/NZAvQSf5A9BT5b/c7s+0E/wAIOR9aANMyqTwRjHTNNaXOGONvvz/ntWS96gI5zgdc0w34wQCGH1/SgDVklG4hjnJz1I/Oq8s2H4P4A9KzGv8AByMkn1OKqy3xXgDnoeaAPGP2sJN+meHx6zSk46fdWvm+vfv2nLn7Rp+hZJyJZeCf9la8BoA1fCmoxaP4p0fUrlXaCzvIbiRYwCxVHDEDJAzgeor6QP7Q/hc9dO1v/v1F/wDHK+WqKAPqYftEeFwCP7O1v/vzF/8AHKd/w0V4X76drf8A35i/+OV8r0UAfVK/tF+F8gnTtbz3/cwn/wBqUN+0V4WJ/wCQdreO/wC4i/8AjlfK1FAH1Uv7RfhUf8w7XMe0MX/xynf8NG+FwpUafru09vKi/wDjlfKdFAH1S37RXhYgY0/XOP8ApjF/8cpp/aI8LHGLDXBj/phF/wDHK+WKKAPqcftEeF+n9n62B7Qxf/HKT/hofwuQAdP1vAHaGL/47XyzRQB9Sf8ADQvhcgg6frZGP+eEXP8A5EqKX9oDwsxyun62D6+TF/8AHK+YKKAPqMftC+F8DOn60f8AthF/8cp4/aI8L5OdP1wA+kUX/wAdr5ZooA+p/wDhonwweun61wMZ8mL/AOOU4/tFeF2OTp2tj6Qxf/HK+VqKAPqlv2i/C5H/ACD9cyOmYYv/AI5UTftEeGixJ0/Wj9YYv/jlfLdFAH0/J+0J4cf/AJcNZA9oYv8A45WfP8dfDsp5s9YOepMMWf8A0ZXzhRQB9Ej43eHBjFjq5x/0yjH/ALUpy/HDw4CSbLWDn/plH+f+sr50ooA+jo/jn4cQDNhq5Pf91H/8cqdfj14cAI+w6x/36j/+OV81UUAfSrfHrw4RgWOsY6f6qL/45SD49+HgpAsdX9f9TH/8cr5rooA+lf8Ahfnh7/nx1f2/cx8f+RKa3x68PEDFjq/Bz/qo+f8AyJXzZRQB9Kf8L68PZz9i1j6CKL/45Tf+F8+Hu1jq+c5z5UfH/kSvm2igD6TPx48OHP8AoOsD/tlF/wDHKiPx28PnrY6sf+2Uf/xyvnGigD6LPxy8PEf8eWr/APfqP/45UD/G3Qi25bTVsg55ij/+OV890UAeifFTxvp/i6309NPhvI2t3dmNwqrnIHTDH0rzuiigD//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cross-sectioned axoneme from a man with normal, motile cilia and spermatozoa. Nine microtubular doublets form a circle, 0.2 micrometer wide, surrounding two central microtubules. Along each of the nine doublets there is a row of outer dynein arms and a row of inner dynein arms. These dynein arms are the force-producing elements in cilia and sperm flagella.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Afzelius, BA, Dallai, R, Lanzavecchia, S, Bellon, PL. Flagellar structure in normal human spermatozoa and in spermatozoa that lack dynein arms. Tissue Cell 1995 27:241.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10438=[""].join("\n");
var outline_f10_12_10438=null;
var title_f10_12_10439="Clinical manifestations and diagnosis of acute intermittent porphyria";
var content_f10_12_10439=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of acute intermittent porphyria",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/12/10439/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/12/10439/contributors\">",
"     Gagan K Sood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/12/10439/contributors\">",
"     Karl E Anderson, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/12/10439/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/12/10439/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/12/10439/contributors\">",
"     Donald H Mahoney, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/12/10439/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/12/10439/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/12/10439/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute intermittent porphyria (AIP, Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is an autosomal dominant disorder resulting from a partial deficiency of porphobilinogen deaminase (PBGD, hydroxymethylbilane synthase, previously called uroporphyrinogen I synthase), the third enzyme in the heme biosynthetic pathway (",
"    <a class=\"graphic graphic_figure graphicRef68187 \" href=\"UTD.htm?24/31/25077\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef57890 \" href=\"UTD.htm?34/50/35617\">",
"     figure 2",
"    </a>",
"    ). Symptoms in AIP are due to effects on the visceral, peripheral, autonomic, and central nervous systems. They usually occur as intermittent attacks that are sometimes life-threatening [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations and diagnosis of AIP will be reviewed here. The etiology, pathogenesis, and management of AIP and an overview of the porphyrias are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/16/40198?source=see_link\">",
"     \"Etiology and pathogenesis of acute intermittent porphyria\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/20/3398?source=see_link\">",
"     \"Management of acute intermittent porphyria\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/19/28984?source=see_link\">",
"     \"Porphyrias: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most individuals with acute intermittent porphyria (AIP, ie, those who inherit a porphobilinogen deaminase mutation) never develop symptoms. Accordingly, symptomatic disease may skip generations or be recognized in only one individual within a family. The presentation is highly variable and the symptoms are nonspecific, which accounts in part for delays in diagnosis. Symptoms usually occur as acute attacks, most often in the third or fourth decades of life, and are more common in women than in men. The most common manifestations of AIP are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef56856 \" href=\"UTD.htm?26/3/26683\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Attacks in AIP develop over hours or days and persist for days or weeks, depending upon precipitating factors and treatment. There are no cutaneous manifestations. Rare exceptions are patients with AIP and advanced renal failure, who may develop elevations in plasma porphyrins and blistering skin lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Abdominal and urinary symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abdominal pain is the most common symptom in AIP, occurring in 85 to 95 percent of patients with acute attacks (",
"    <a class=\"graphic graphic_table graphicRef56856 \" href=\"UTD.htm?26/3/26683\">",
"     table 1",
"    </a>",
"    ). It is usually severe, steady, and poorly localized but is sometimes cramping, and is often accompanied by constipation and signs of ileus such as nausea, vomiting, abdominal distension, and decreased bowel sounds. However, diarrhea and increased bowel sounds are sometimes seen.",
"   </p>",
"   <p>",
"    Because the pain and other symptoms are neuropathic rather than inflammatory, abdominal tenderness, rebound, fever, and leukocytosis are usually minimal or absent during an acute attack. Bladder dysfunction may cause urinary retention, incontinence, and dysuria. Dark or reddish-brown urine is often an early symptom&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/1,2,4-6\">",
"     1,2,4-6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/16/40198?source=see_link&amp;anchor=H3#H3\">",
"     \"Etiology and pathogenesis of acute intermittent porphyria\", section on 'Metabolic defect'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Peripheral neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sensory neuropathy is common and presents with pain in the back, chest, and extremities, and may precede the abdominal pain. Patchy numbness, paresthesias, and dysesthesias may occur. A peripheral motor neuropathy develops early in some attacks, but is more often a later manifestation of a prolonged attack.",
"   </p>",
"   <p>",
"    Motor weakness usually begins proximally in the upper and lower extremities and may progress distally. Especially with prolonged attacks, it may also involve cranial nerves and lead to bulbar paralysis, respiratory impairment, and death. Although advanced motor neuropathy with quadriplegia and respiratory paralysis is potentially reversible with appropriate treatment (eg, intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/39/21107?source=see_link\">",
"     hemin",
"    </a>",
"    ), some permanent paralysis may remain [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Systemic and central nervous system involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;The autonomic nervous system is affected in AIP and circulating catecholamine levels are increased [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/9\">",
"     9",
"    </a>",
"    ]. Tachycardia is the most common physical sign, occurring in approximately 80 percent of attacks, and is often accompanied by hypertension, sweating, restlessness, and tremor. Insomnia is often an early symptom of an attack.",
"   </p>",
"   <p>",
"    Other neuropsychiatric manifestations include anxiety, restlessness, agitation, hallucinations, hysteria, disorientation, delirium, apathy, depression, phobias and altered consciousness, ranging from somnolence to coma. Cerebral manifestations may be accompanied by MRI changes that suggest vasospasm [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/10\">",
"     10",
"    </a>",
"    ]. Seizures may be due to hyponatremia or represent a neurological manifestation of porphyria. Long-term psychiatric symptoms such as depression occurring apart from acute attacks may be seen but are more difficult to attribute to porphyria [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Electrolyte and metabolic abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyponatremia during an acute attack may be due to hypothalamic involvement and the syndrome of inappropriate antidiuretic hormone secretion (SIADH), but other mechanisms, such as gastrointestinal or renal sodium loss are sometimes important [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/5\">",
"     5",
"    </a>",
"    ]. Other electrolyte abnormalities may include hypomagnesemia and hypercalcemia [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/46/7913?source=see_link\">",
"     \"Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Long term effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of the acute porphyrias usually occur as acute attacks, with interval resolution. However, some patients develop chronic pain and other long-term symptoms including depression and anxiety, especially after multiple recurrent attacks. These patients are at increased risk for suicide and require adequate pain management and psychiatric monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/2,11\">",
"     2,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Persistent elevations is serum transaminases are common, especially in patients who have had repeated disease exacerbations [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. It is not clear if there is a risk for developing cirrhosis. However, there is clearly a substantially increased risk of hepatocellular carcinoma, especially after age 50 [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/14-22\">",
"     14-22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Persistent hypertension and the development of chronic renal disease are increasingly recognized in patients with AIP [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/13,23,24\">",
"     13,23,24",
"    </a>",
"    ]. Renal histology may reveal interstitial disease rather than findings attributable to hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/25\">",
"     25",
"    </a>",
"    ]. A number of patients have required dialysis or renal transplantation, which are generally well tolerated [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     AIP in children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute attacks of porphyria are exceedingly rare before puberty and well-documented instances are not described in the literature. In a Swedish registry of 464 DNA-confirmed cases of AIP with or without symptoms, 78 were under 18 years of age; 61 of the 78 were followed for approximately 2.5 years, during which time symptoms developed in 6 (10 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/27\">",
"     27",
"    </a>",
"    ]. In all six cases, symptoms occurred before the age of 15 years, but were generally vague and of short duration, and none had paresis or other severe symptoms. Moreover, urinary levels of ALA and PBG were elevated only slightly or not at all, and it was not determined in this population-based study whether the vague symptoms described were more common in children who had inherited an AIP gene than in those who did not.",
"   </p>",
"   <p>",
"    Children of AIP gene carriers should be DNA tested and counseled on preventive measures to avoid developing manifest AIP, recognizing that the danger of attacks will increase after puberty.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;An accurate diagnosis of acute porphyria is important in order to institute appropriate therapy and avoid progressive neurological impairment. Because the presenting symptoms and signs are nonspecific, a high index of suspicion is required for the initial diagnosis of acute porphyria. Reliance on a few first-line screening tests, primarily measurement of urinary porphobilinogen (PBG), is more cost effective than ordering all available porphyria testing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     First line testing with urinary PBG",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of AIP, hereditary coproporphyria (HCP), or variegate porphyria (VP) can be ruled in or out by assessing urinary PBG in patients with unexplained abdominal pain or other suggestive symptoms if the initial evaluation does not suggest a more common explanation. However, PBG may not be elevated when the patient with AIP, HCP, or VP is asymptomatic, and is normal in ALA dehydratase porphyria. A kit for semiquantitative estimation urinary PBG has replaced the older and less reliable Watson-Schwarz and Hoesch tests for rapid recognition of an elevation of this porphyrin precursor.",
"   </p>",
"   <p>",
"    Testing for increased urinary PBG is rapid and sensitive, since marked increases are expected in acute porphyrias, especially at the time of an acute attack. In patients with end-stage renal disease, the diagnosis of acute porphyria can be established by the presence of a marked elevation in plasma PBG [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Testing for increased urinary PBG is also highly specific, since a substantial increase in urinary PBG does not occur in medical conditions other than AIP, HCP and VP. Increased excretion of urinary porphyrins is less specific and occurs in many medical conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A commercially-available semiquantitative kit rapidly and reliably detects increased urinary PBG on a",
"    <strong>",
"     spot",
"    </strong>",
"    urine specimen [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/29\">",
"     29",
"    </a>",
"    ]. During an acute attack of AIP, urinary PBG excretion is generally 20 to 200",
"    <span class=\"nowrap\">",
"     mg/day,",
"    </span>",
"    markedly higher than the normal rate of approximately 0 to 4",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    or per gram of creatinine. The marked increase in PBG excretion during an acute episode means that variations in water intake and therefore the urine volume (eg, a reduction in PBG concentration with a high urine volume) should not interfere with test performance using a spot urine rather than a 24-hour collection.",
"   </p>",
"   <p>",
"    Finding a substantial increase in urinary or plasma PBG establishes that a patient has AIP, hereditary coproporphyria (HCP), or variegate porphyria (VP). Treatment can then be started immediately, while further laboratory testing is performed on samples collected before treatment to establish the type of acute porphyria. A diagnostic flow chart for use when acute porphyria is suspected is shown in the algorithm (",
"    <a class=\"graphic graphic_algorithm graphicRef61709 \" href=\"UTD.htm?26/12/26831\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Differentiating AIP from other acute porphyrias'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Further testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a screening test for increased urinary PBG is negative on a spot urine specimen but the index of suspicion is high for an acute porphyria, a 24-hour urine collection should be obtained for quantitative assessment of delta-aminolevulinic acid (ALA), PBG, and total porphyrins. This will confirm the screening PBG result and also detect increased ALA, as found in the rare condition ALA dehydratase porphyria (ADP), the symptoms and treatment of which are identical to those of AIP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/33/5656?source=see_link\">",
"     \"ALA dehydratase porphyria\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Substantial increases in urinary porphyrins, although nonspecific, may suggest the diagnosis of HCP or VP, since urinary PBG and ALA are less increased and fall more rapidly in these disorders than in AIP.",
"   </p>",
"   <p>",
"    During an acute attack of AIP, urinary PBG excretion is generally 20 to 200",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    (normal 0 to 4",
"    <span class=\"nowrap\">",
"     mg/day),",
"    </span>",
"    with ALA excretion being approximately one-half that amount (normal range 0 to 7",
"    <span class=\"nowrap\">",
"     mg/day).",
"    </span>",
"    Urinary ALA and PBG excretion often remains elevated between frequent exacerbations, and is sometimes elevated in those who have never had symptoms.",
"   </p>",
"   <p>",
"    The diagnosis of an acute attack in a patient with an increased urinary PBG concentration is largely clinical, and is not based on achieving a specific level of PBG and ALA for the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Baseline levels of PBG and ALA fluctuate considerably and can be difficult to establish between attacks [",
"      <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      When administered, intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/39/21107?source=see_link\">",
"       hemin",
"      </a>",
"      causes dramatic, rapid, but often transient, decreases in PBG and ALA.",
"     </li>",
"     <li>",
"      Increases in PBG and ALA can persist for prolonged periods between attacks of AIP but, as noted above, fall more rapidly after acute attacks of HCP and VP.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Differentiating AIP from other acute porphyrias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Attacks of all four of the acute porphyrias (ie, acute intermittent porphyria, ALA dehydratase porphyria, hereditary coproporphyria, variegate porphyria) (",
"    <a class=\"graphic graphic_table graphicRef51032 \" href=\"UTD.htm?25/1/25627\">",
"     table 2",
"    </a>",
"    ) are treated in the same manner. As a result, treatment can be initiated once there is definite laboratory documentation of a substantial increase in urinary or plasma PBG, while further testing, including measurement of porphyrins in plasma, urine, and feces, and erythrocyte PBG deaminase (PBGD) activity is in progress. This additional testing utilizes the original spot urine sample and samples of blood and feces collected before starting treatment.",
"   </p>",
"   <p>",
"    Although erythrocyte PBGD activity is approximately half-normal in most patients with AIP, this measurement is not definitive for confirming or excluding a diagnosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The wide ranges of activity for this enzyme in normals and AIP overlap.",
"     </li>",
"     <li>",
"      As described earlier, some PBGD mutations cause the enzyme to be deficient only in non-erythroid tissues. Moreover, the wide ranges of activity for this enzyme in normals and AIP overlap. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/16/40198?source=see_link&amp;anchor=H4#H4\">",
"       \"Etiology and pathogenesis of acute intermittent porphyria\", section on 'Molecular pathology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Because erythrocyte PBGD enzyme activity is highly dependent upon red blood cell age [",
"      <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/31\">",
"       31",
"      </a>",
"      ], an increase in the proportion of younger red blood cells in the circulation (which may not always have the appearance of reticulocytes) can raise the activity into the normal range in AIP patients with a concurrent condition such as hemolytic anemia or hepatic disease [",
"      <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/32,33\">",
"       32,33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      This measurement does not distinguish between latent and active disease, and does not detect the other acute porphyrias (ie, ADP, HCP, VP).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For all these reasons, erythrocyte PBGD measurement is not useful for the",
"    <strong>",
"     initial",
"    </strong>",
"    diagnosis of acute porphyria in ill patients. Its use as a second line test to confirm a diagnosis of AIP and for screening asymptomatic family members is now largely replaced by DNA testing.",
"   </p>",
"   <p>",
"    Measurements of total plasma and fecal porphyrins, which are normal or only slightly increased in AIP, are recommended to definitively exclude HCP and VP (",
"    <a class=\"graphic graphic_table graphicRef60572 \" href=\"UTD.htm?4/23/4477\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plasma porphyrins are increased in VP with a characteristic fluorescence peak at neutral pH [",
"      <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fecal porphyrins are normal or minimally increased in AIP but substantially increased in HCP (with a marked predominance of coproporphyrin III) and in VP (with approximately equal increases in coproporphyrin III and protoporphyrin) [",
"      <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Urinary coproporphyrin is usually more elevated in HCP and VP than in AIP. However, coproporphyrin is the predominant porphyrin in normal urine and is also increased in many medical conditions other than porphyria. Its urinary excretion increases in liver disease because it is normally partially excreted in bile [",
"      <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Erythrocyte zinc protoporphyrin concentrations may be modestly and nonspecifically increased in AIP, HCP and VP, and are markedly increased in ADP [",
"      <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     DNA testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The underlying PBGD mutation should be identified by DNA testing after the diagnosis of AIP is established by biochemical methods. This not only further confirms the diagnosis, but most importantly enables accurate identification of other gene carriers in a family. Although PBGD deficiency can be documented in the fetus by measuring the enzyme activity or by identifying the parental mutation in amniotic fluid cells, this is usually not indicated because the great majority of heterozygous carriers of PBGD mutations have a good prognosis and remain asymptomatic during their lifetime [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10439/abstract/2\">",
"     2",
"    </a>",
"    ]. Moreover, attacks of acute porphyria are rare in children, thus reducing the urgency of making a diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Suspecting the diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of acute intermittent porphyria (AIP) should be suspected in patients presenting with otherwise unexplained neurovisceral complaints such as abdominal pain, vomiting, constipation, or muscle weakness (",
"    <a class=\"graphic graphic_table graphicRef56856 \" href=\"UTD.htm?26/3/26683\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Manifestations of AIP such as hypertension, hyponatremia, seizures, quadriplegia, or respiratory paralysis may be life-threatening, requiring prompt diagnosis and treatment. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Clinical manifestations'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Confirming the diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of one of the three most common acute porphyrias is confirmed by the finding of a substantially increased concentration of porphobilinogen (PBG) using a spot urine specimen (",
"    <a class=\"graphic graphic_algorithm graphicRef61709 \" href=\"UTD.htm?26/12/26831\">",
"     algorithm 1",
"    </a>",
"    ). Treatment can be started, if indicated clinically, while further testing is in progress. The urine specimen should be saved for later measurement of delta-aminolevulinic acid (ALA) and total porphyrins. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'First line testing with urinary PBG'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The specific diagnosis of AIP is confirmed in a patient with a substantial increase in PBG by finding normal or only slight elevations in plasma and fecal porphyrins, in most cases by decreased enzymatic activity of erythrocyte porphobilinogen deaminase (PBGD), and by DNA studies. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of one of the other acute porphyrias (ie, ALA dehydratase porphyria, hereditary coproporphyria, variegate porphyria) is confirmed by measuring plasma, erythrocyte, and fecal porphyrins and urinary ALA (",
"      <a class=\"graphic graphic_table graphicRef60572 \" href=\"UTD.htm?4/23/4477\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Differentiating AIP from other acute porphyrias'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/19/28984?source=see_link&amp;anchor=H11#H11\">",
"       \"Porphyrias: An overview\", section on 'Acute porphyrias'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Treatment of AIP and the other acute porphyrias is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/20/3398?source=see_link\">",
"       \"Management of acute intermittent porphyria\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Anderson KE, Sassa S, Bishop DF, Desnick RJ. Disorders of heme biosynthesis: X-linked sideroblastic anemias and the porphyrias. In: The Metabolic and Molecular Basis of Inherited Disease, 8th ed, Scriver CR, Beaudet AL, Sly WS, et al. (Eds), McGraw-Hill, New York 2001. p.2991.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/2\">",
"      Anderson KE, Bloomer JR, Bonkovsky HL, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med 2005; 142:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/3\">",
"      Sardh E, Andersson DE, Henrichson A, Harper P. Porphyrin precursors and porphyrins in three patients with acute intermittent porphyria and end-stage renal disease under different therapy regimes. Cell Mol Biol (Noisy-le-grand) 2009; 55:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/4\">",
"      WALDENSTROM J. The porphyrias as inborn errors of metabolism. Am J Med 1957; 22:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/5\">",
"      Tschudy DP, Valsamis M, Magnussen CR. Acute intermittent porphyria: clinical and selected research aspects. Ann Intern Med 1975; 83:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/6\">",
"      Stein JA, Tschudy DP. Acute intermittent porphyria. A clinical and biochemical study of 46 patients. Medicine (Baltimore) 1970; 49:1.",
"     </a>",
"    </li>",
"    <li>",
"     Ridley A. Porphyric neuropathy. In: Peripheral neuropathy, Dyck PJ, Thomas PK, Lambert EH, Bunge R (Eds), WB Saunders Co, Philadelphia 1984. p.1704.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/8\">",
"      Wikberg A, Andersson C, Lithner F. Signs of neuropathy in the lower legs and feet of patients with acute intermittent porphyria. J Intern Med 2000; 248:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/9\">",
"      Beal MF, Atuk NO, Westfall TC, Turner SM. Catecholamine uptake, accumulation, and release in acute porphyria. J Clin Invest 1977; 60:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/10\">",
"      Sze G. Cortical brain lesions in acute intermittent porphyria. Ann Intern Med 1996; 125:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/11\">",
"      Jeans JB, Savik K, Gross CR, et al. Mortality in patients with acute intermittent porphyria requiring hospitalization: a United States case series. Am J Med Genet 1996; 65:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/12\">",
"      Ostrowski J, Kostrzewska E, Michalak T, et al. Abnormalities in liver function and morphology and impaired aminopyrine metabolism in hereditary hepatic porphyrias. Gastroenterology 1983; 85:1131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/13\">",
"      Bylesj&ouml; I, Wikberg A, Andersson C. Clinical aspects of acute intermittent porphyria in northern Sweden: a population-based study. Scand J Clin Lab Invest 2009; 69:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/14\">",
"      Andant C, Puy H, Bogard C, et al. Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. J Hepatol 2000; 32:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/15\">",
"      Andant C, Puy H, Faivre J, Deybach JC. Acute hepatic porphyrias and primary liver cancer. N Engl J Med 1998; 338:1853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/16\">",
"      Andersson C, Bjersing L, Lithner F. The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria. J Intern Med 1996; 240:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/17\">",
"      Bengtsson NO, Hardell L. Porphyrias, porphyrins and hepatocellular cancer. Br J Cancer 1986; 54:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/18\">",
"      Gubler JG, Bargetzi MJ, Meyer UA. Primary liver carcinoma in two sisters with acute intermittent porphyria. Am J Med 1990; 89:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/19\">",
"      Hardell L, Bengtsson NO, Jonsson U, et al. Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria--an epidemiological investigation. Br J Cancer 1984; 50:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/20\">",
"      Kauppinen R, Mustajoki P. Acute hepatic porphyria and hepatocellular carcinoma. Br J Cancer 1988; 57:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/21\">",
"      Linet MS, Gridley G, Nyr&eacute;n O, et al. Primary liver cancer, other malignancies, and mortality risks following porphyria: a cohort study in Denmark and Sweden. Am J Epidemiol 1999; 149:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/22\">",
"      Lithner F, Wetterberg L. Hepatocellular carcinoma in patients with acute intermittent porphyria. Acta Med Scand 1984; 215:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/23\">",
"      Church SE, McColl KE, Moore MR, Youngs GR. Hypertension and renal impairment as complications of acute porphyria. Nephrol Dial Transplant 1992; 7:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/24\">",
"      Andersson C, Wikberg A, Stegmayr B, Lithner F. Renal symptomatology in patients with acute intermittent porphyria. A population-based study. J Intern Med 2000; 248:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/25\">",
"      Marsden JT, Chowdhury P, Wang J, et al. Acute intermittent porphyria and chronic renal failure. Clin Nephrol 2008; 69:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/26\">",
"      Barone GW, Gurley BJ, Anderson KE, et al. The tolerability of newer immunosuppressive medications in a patient with acute intermittent porphyria. J Clin Pharmacol 2001; 41:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/27\">",
"      Hultdin J, Schmauch A, Wikberg A, et al. Acute intermittent porphyria in childhood: a population-based study. Acta Paediatr 2003; 92:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/28\">",
"      Kauppinen R, von und zu Fraunberg M. Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families. Clin Chem 2002; 48:1891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/29\">",
"      Deacon AC, Peters TJ. Identification of acute porphyria: evaluation of a commercial screening test for urinary porphobilinogen. Ann Clin Biochem 1998; 35 ( Pt 6):726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/30\">",
"      Floderus Y, Sardh E, M&ouml;ller C, et al. Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion. Clin Chem 2006; 52:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/31\">",
"      Anderson KE, Sassa S, Peterson CM, Kappas A. Increased erythrocyte uroporphyrinogen-l-synthetase, delta-aminolevulinic acid dehydratase and protoporphyrin in hemolytic anemias. Am J Med 1977; 63:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/32\">",
"      Blum M, Koehl C, Abecassis J. Variations in erythrocyte uroporphyrinogen I synthetase activity in non porphyrias. Clin Chim Acta 1978; 87:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/33\">",
"      Kostrzewska E, Gregor A. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria. Ann Clin Res 1986; 18:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/34\">",
"      Poh-Fitzpatrick MB. A plasma porphyrin fluorescence marker for variegate porphyria. Arch Dermatol 1980; 116:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/35\">",
"      Blake D, McManus J, Cronin V, Ratnaike S. Fecal coproporphyrin isomers in hereditary coproporphyria. Clin Chem 1992; 38:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/36\">",
"      Gibson PR, Grant J, Cronin V, et al. Effect of hepatobiliary disease, chronic hepatitis C and hepatitis B virus infections and interferon-alpha on porphyrin profiles in plasma, urine and faeces. J Gastroenterol Hepatol 2000; 15:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10439/abstract/37\">",
"      Akagi R, Kato N, Inoue R, et al. delta-Aminolevulinate dehydratase (ALAD) porphyria: the first case in North America with two novel ALAD mutations. Mol Genet Metab 2006; 87:329.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7096 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-221.179.173.170-312020EB49-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10439=[""].join("\n");
var outline_f10_12_10439=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Abdominal and urinary symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Peripheral neuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Systemic and central nervous system involvement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Electrolyte and metabolic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Long term effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      AIP in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      First line testing with urinary PBG",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Further testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Differentiating AIP from other acute porphyrias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DNA testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Suspecting the diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Confirming the diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/7096\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7096|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?26/12/26831\" title=\"algorithm 1\">",
"      Diagnosis acute porphyria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7096|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/31/25077\" title=\"figure 1\">",
"      Heme synthesis and porphyria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/50/35617\" title=\"figure 2\">",
"      Heme biosynthetic pathway",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7096|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/3/26683\" title=\"table 1\">",
"      Symptoms and signs in AIP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/1/25627\" title=\"table 2\">",
"      Acute porphyrias features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/23/4477\" title=\"table 3\">",
"      Excretion patterns",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/33/5656?source=related_link\">",
"      ALA dehydratase porphyria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/16/40198?source=related_link\">",
"      Etiology and pathogenesis of acute intermittent porphyria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/20/3398?source=related_link\">",
"      Management of acute intermittent porphyria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/46/7913?source=related_link\">",
"      Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/19/28984?source=related_link\">",
"      Porphyrias: An overview",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_12_10440="Vincents curtsy";
var content_f10_12_10440=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75506&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75506&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 544px\">",
"   <div class=\"ttl\">",
"    Holding maneuvers in children with voiding dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 524px; height: 591px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Image courtesy of Dr. Laurence Baskin, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10440=[""].join("\n");
var outline_f10_12_10440=null;
var title_f10_12_10441="Cross section of female pelvis";
var content_f10_12_10441=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F83640&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F83640&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 613px\">",
"   <div class=\"ttl\">",
"    Cross section of female pelvis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 593px; height: 444px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Moore KL, Dalley AF, Agur AMR. Pelvis and perineum. In: Clinically Oriented Anatomy, 6th ed, Lippincott Williams &amp; Wilkins, Baltimore, 2010. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10441=[""].join("\n");
var outline_f10_12_10441=null;
var title_f10_12_10442="Overview of the treatment of disseminated prostate cancer";
var content_f10_12_10442=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of the treatment of disseminated prostate cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/12/10442/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/12/10442/contributors\">",
"     Nancy A Dawson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/12/10442/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/12/10442/contributors\">",
"     Nicholas Vogelzang, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/12/10442/contributors\">",
"     W Robert Lee, MD, MS, MEd",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/12/10442/contributors\">",
"     Jerome P Richie, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/12/10442/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/12/10442/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/12/10442/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 9, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most cases of prostate cancer are diagnosed and treated while disease is localized, some men have evidence of metastatic at presentation and others develop disseminated disease after their definitive treatment. Contemporary research has led to the development of multiple active treatment modalities for men with advanced disease. Management of men with advanced prostate cancer involves the sequential use of these and older approaches, with the goals of prolonging survival, minimizing complications, and maintaining quality of life.",
"   </p>",
"   <p>",
"    An overview of treatment options for patients with disseminated prostate cancer and considerations for the proper sequencing of the various treatment options are presented here.",
"   </p>",
"   <p>",
"    The initial management of men with localized prostate cancer is discussed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16969?source=see_link\">",
"       \"Initial approach to low-risk clinically localized prostate cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/26/21930?source=see_link\">",
"       \"Initial management of regionally localized intermediate and high risk prostate cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H261299175\">",
"    <span class=\"h1\">",
"     PATIENT POPULATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some men with prostate cancer will have overt metastases either at presentation or as their first sign of recurrence following definitive therapy. In the vast majority of cases, such metastases are predominantly osteoblastic lesions in the axial skeleton. However, in some cases the only manifestation of disseminated disease is an elevated or rising serum PSA after definitive therapy.",
"   </p>",
"   <p>",
"    Systemic therapy options for men in whom the only evidence of disseminated disease is an elevated PSA are the same as those for men with overt metastases. However, disease manifested only by an elevated serum PSA may have a very prolonged natural history, which has significant implications for the timing and choice of therapy. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/48/33544?source=see_link&amp;anchor=H81453304#H81453304\">",
"     \"Rising serum PSA following local therapy for prostate cancer: Definition, natural history, and risk stratification\", section on 'Prognosis after biochemical failure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/48/30470?source=see_link\">",
"     \"Rising serum PSA after treatment for localized prostate cancer: Systemic therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H261299183\">",
"    <span class=\"h1\">",
"     SEQUENCE OF SYSTEMIC THERAPIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H261299582\">",
"    <span class=\"h2\">",
"     Androgen deprivation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Previously untreated prostate cancer is dependent upon androgen at least initially for its continued growth in most cases. Androgen production occurs primarily in the testes, which account for 90 to 95 percent of total circulating testosterone; testicular production of androgen is regulated by the hypothalamic pituitary axis. The adrenal glands produce the remainder of the circulating androgens.",
"   </p>",
"   <p>",
"    These observations provide the rationale for androgen deprivation therapy (ADT), which is the standard initial approach for patients with metastatic prostate cancer or an elevated serum PSA when systemic therapy is indicated. ADT can be accomplished either with bilateral orchiectomy (surgical castration) or medical orchiectomy. (See",
"    <a class=\"local\" href=\"#H25221296\">",
"     'Androgen deprivation therapy'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H25#H25\">",
"     \"Initial hormone therapy for metastatic prostate cancer\", section on 'Timing of ADT'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H261299639\">",
"    <span class=\"h2\">",
"     Castrate resistant disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients being managed with ADT who have evidence of disease progression (increasing serum PSA, new clinical metastases, progression of existing metastases) are considered to have castrate resistant disease.",
"   </p>",
"   <p>",
"    Contemporary research in men with castrate resistant prostate cancer has led to the development of multiple agents that improved overall survival in phase III trials (",
"    <a class=\"graphic graphic_table graphicRef85716 \" href=\"UTD.htm?17/56/18317\">",
"     table 1",
"    </a>",
"    ). These include agents that interfere with androgenic stimulation of prostate cancer growth (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"     enzalutamide",
"    </a>",
"    ), taxane chemotherapy (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/47/31478?source=see_link\">",
"     cabazitaxel",
"    </a>",
"    ), immunotherapy (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/18/12581?source=see_link\">",
"     sipuleucel-T",
"    </a>",
"    ), and a bone targeted radiopharmaceutical (radium-223). In addition, there are a number of older endocrine approaches that may retain utility in selected situations and have not been adequately studied in randomized trials. (See",
"    <a class=\"local\" href=\"#H261299899\">",
"     'Castrate resistant disease'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    These newer therapeutic approaches have each been evaluated in a relative limited segment of the potential patient population and have not been compared with each other in randomized trials. The observed benefit in survival with each is of similar magnitude and results cannot be directly compared because of differences in patient populations.",
"   </p>",
"   <p>",
"    The proper sequencing of these newer approaches requires a consideration of multiple factors (",
"    <a class=\"graphic graphic_table graphicRef85716 \" href=\"UTD.htm?17/56/18317\">",
"     table 1",
"    </a>",
"    ). The sites and extent of disease involvement, along with the rate of disease progression, are particularly important considerations in choosing therapy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      None of the newer modalities has been adequately evaluated in men whose only evidence of disseminated disease is an elevated or rising serum PSA after definitive surgery or radiation therapy. The optimal management of patients whose only evidence of disease is a rising or elevated PSA thus is extrapolated from patients with more extensive disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/48/30470?source=see_link\">",
"       \"Rising serum PSA after treatment for localized prostate cancer: Systemic therapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/18/12581?source=see_link\">",
"       Sipuleucel-T",
"      </a>",
"      &ndash; The dendritic cell vaccine sipuleucel-T was studied only in the context of asymptomatic or minimally symptomatic men with metastases. This approach has not been studied in men whose only evidence of disease is an elevated PSA or in those with symptomatic metastases. Furthermore, treatment with sipuleucel-T does not affect the serum PSA, restricting this approach to patients with slowly progressive disease where a relatively rapid response to treatment is not required. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/14/1254?source=see_link&amp;anchor=H3#H3\">",
"       \"Immunotherapy for castration resistant prostate cancer\", section on 'Sipuleucel-T'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"       Abiraterone",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"       enzalutamide",
"      </a>",
"      &ndash; Both abiraterone and enzalutamide act by interfering with the androgenic stimulation of tumor growth. The initial phase III trial with each of these agents was conducted in patients who had progressed after treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"       docetaxel",
"      </a>",
"      chemotherapy. However, their mechanism of action, oral administration, and side effect profile may make these agents suitable for use in chemotherapy na&iuml;ve patients once adequate data are available. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16503?source=see_link&amp;anchor=H1409980#H1409980\">",
"       \"Castrate resistant prostate cancer: Treatments targeting the androgen pathway\", section on 'Abiraterone'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16503?source=see_link&amp;anchor=H1385299855#H1385299855\">",
"       \"Castrate resistant prostate cancer: Treatments targeting the androgen pathway\", section on 'Enzalutamide'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Taxane chemotherapy &ndash; Cytotoxic chemotherapy with a taxane is generally reserved for patients with relatively rapidly progressive, symptomatic disease for which less toxic approaches are not an appropriate option.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"       Docetaxel",
"      </a>",
"      is the preferred agent in this setting.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/47/31478?source=see_link\">",
"       Cabazitaxel",
"      </a>",
"      has only been studied in the context of patients who have progressed on docetaxel. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6280?source=see_link\">",
"       \"Chemotherapy in castrate-resistant prostate cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Radium-223 &ndash; The bone-seeking radiopharmaceutical radium-223 is appropriate only for patients with extensive bone metastases but without other visceral metastases, and its evaluation in clinical trials was limited to this setting. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=see_link&amp;anchor=H261306118#H261306118\">",
"       \"Management of bone metastases in advanced prostate cancer\", section on 'Radium-223'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other factors that may influence the choice of therapy include the route and frequency of administration, side effects, regulatory status, regulatory status, cost, insurance reimbursement, and patient preferences.",
"   </p>",
"   <p>",
"    In addition, older endocrine approaches (eg, antiandrogens,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/34/33312?source=see_link\">",
"     ketoconazole",
"    </a>",
"    , steroids) may have an important role, particularly in the management of patients with slowly progressive disease, as a way to forestall using more toxic or expensive alternatives. (See",
"    <a class=\"local\" href=\"#H176001\">",
"     'Other endocrine approaches'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Patients should be included in clinical trials whenever possible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25221296\">",
"    <span class=\"h1\">",
"     ANDROGEN DEPRIVATION THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Androgen deprivation therapy (ADT) is the standard initial approach for patients when systemic therapy is indicated for metastatic prostate cancer or evidence of disseminated disease based upon serum PSA. ADT can be accomplished either with bilateral orchiectomy (surgical castration) or medical orchiectomy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link\">",
"     \"Initial hormone therapy for metastatic prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Bilateral orchiectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bilateral orchiectomy (surgical castration) is a simple, cost-effective procedure. Following surgery, serum testosterone levels rapidly decrease to castrate levels. In many countries, bilateral orchiectomy remains the standard of care for initial hormone therapy of metastatic prostate cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H6#H6\">",
"     \"Initial hormone therapy for metastatic prostate cancer\", section on 'Surgical orchiectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgical castration may be particularly useful when an immediate decrease in testosterone is necessary (eg, impending spinal cord compression, urinary tract outlet obstruction) or when cost or adherence to medical therapy are an issue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Medical orchiectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medical orchiectomy decreases testicular production of testosterone by its effects on the hypothalamic pituitary axis. The most widely used approach is continuous treatment with a gonadotropin releasing hormone (GnRH) agonist, which suppresses luteinizing hormone production and therefore the synthesis of testicular androgens. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H8#H8\">",
"     \"Initial hormone therapy for metastatic prostate cancer\", section on 'Mechanism of action'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    With the initiation of treatment with GnRH agonists, there is a transient surge of luteinizing hormone before the luteinizing hormone levels fall. This surge can cause an increase in serum testosterone, which may result in a worsening of disease. This \"flare phenomenon\" may be of particular concern in clinical settings such as impending epidural spinal cord compression or urinary tract outflow obstruction. Antiandrogens (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/23/4470?source=see_link\">",
"     flutamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/2/30758?source=see_link\">",
"     bicalutamide",
"    </a>",
"    ) may be useful in preventing the flare phenomenon. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Combined androgen blockade'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A number of GnRH agonists are available (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"     leuprolide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/22/9574?source=see_link\">",
"     goserelin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/10/17573?source=see_link\">",
"     buserelin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/11/9398?source=see_link\">",
"     triptorelin",
"    </a>",
"    ). Depot formulations are frequently used to permit less frequent treatment administration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H9#H9\">",
"     \"Initial hormone therapy for metastatic prostate cancer\", section on 'Formulations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The GnRH antagonist",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/42/15013?source=see_link\">",
"     degarelix",
"    </a>",
"    binds to the GnRH receptors on pituitary gonadotropin-producing cells but does not cause an initial release of luteinizing hormone. Degarelix suppresses testosterone production and avoids the flare phenomenon observed with GnRH agonists; a GnRH antagonist may be a useful alternative to a GnRH agonist when an immediate decrease in testosterone levels is required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H11#H11\">",
"     \"Initial hormone therapy for metastatic prostate cancer\", section on 'GnRH antagonists'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Combined androgen blockade",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antiandrogens bind to androgen receptors and competitively inhibit their interaction with testosterone and dihydrotestosterone. The use of antiandrogens with a GnRH thus produces a combined androgen blockade. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H261287030#H261287030\">",
"     \"Initial hormone therapy for metastatic prostate cancer\", section on 'Combined androgen blockade'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H347804711#H347804711\">",
"     \"Initial hormone therapy for metastatic prostate cancer\", section on 'Antiandrogens'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Combined androgen blockade is widely used for two to four weeks during the initiation of treatment with a GnRH agonist in order to prevent a disease flare due to the transient increase in testosterone levels. Combined androgen blockade is sometimes considered for long-term therapy to improve on the efficacy of a GnRH alone, although its long-term use is limited by costs and increased toxicity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H261287030#H261287030\">",
"     \"Initial hormone therapy for metastatic prostate cancer\", section on 'Combined androgen blockade'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H456228329\">",
"    <span class=\"h2\">",
"     ADT plus chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sequential therapy with ADT alone and the later addition of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    to ADT remains the standard of care. There is no indication for the addition of chemotherapy to ADT in men with hormone sensitive metastatic prostate cancer, even though docetaxel can prolong overall survival in men with castrate resistant disease [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/1\">",
"     1",
"    </a>",
"    ]. &nbsp;(See",
"    <a class=\"local\" href=\"#H95567323\">",
"     'Docetaxel'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In a phase III trial, 385 men with metastatic prostate cancer were randomly assigned to ADT (either a GnRH agonist or orchiectomy) plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    (75",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    every three weeks for up to nine cycles) or to ADT alone [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/2\">",
"     2",
"    </a>",
"    ]. At a median follow-up of 50 months, there was no statistically significant increase in overall survival with the combination compared with ADT alone (median 59 versus 54 months, hazard ratio 1.01, 95% CI 0.75-1.36). There was a statistically significant increase in biochemical progression free survival, but this was accompanied by a significant increase in the incidence of serious adverse events, particularly neutropenia and febrile neutropenia.",
"   </p>",
"   <p>",
"    However, this trial was not statistically powered to detect small differences in overall survival. Data from other phase III trials addressing this issue may provide additional insight.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Continuous versus intermittent ADT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the side effects of ADT are due to castrate levels of serum testosterone. When treatment is withdrawn, serum testosterone levels gradually return toward normal; discontinuation of long-acting GnRH agonists may be associated with a very slow testosterone recovery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H347807333#H347807333\">",
"     \"Initial hormone therapy for metastatic prostate cancer\", section on 'Serum testosterone level'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Intermittent ADT has been proposed as a way to minimize the side effects of medical castration by withholding active therapy once patients have responded to treatment. ADT can then be reinstituted when there is evidence of progression. The time when men are off therapy may be associated with decreased side effects, thereby improving quality of life.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Metastatic disease &mdash; Despite the theoretical advantages of this approach, intermittent ADT is",
"      <strong>",
"       not",
"      </strong>",
"      indicated in patients with metastatic prostate cancer unless survival is considered secondary to quality of life. A phase III intergroup trial found that intermittent ADT could not be considered noninferior compared with continuous ADT in terms of overall survival [",
"      <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H11#H11\">",
"       \"Initial hormone therapy for metastatic prostate cancer\", section on 'GnRH antagonists'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Rising or elevated PSA only &mdash; Intermittent ADT may be appropriate for a subset of men whose only manifestation of disseminated prostate cancer is an elevated or rising serum PSA. A preliminary report of large randomized trial suggested that intermittent ADT was noninferior in terms of overall survival but additional data are required to assess the long-term value of this approach [",
"      <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/4\">",
"       4",
"      </a>",
"      ]. In this setting, intermittent ADT should be limited to well-informed patients who understand the potential risks and benefits of this approach. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/48/30470?source=see_link&amp;anchor=H81459732#H81459732\">",
"       \"Rising serum PSA after treatment for localized prostate cancer: Systemic therapy\", section on 'IAD for PSA only recurrence'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Side effects of ADT",
"    </span>",
"    &nbsp;&mdash;&nbsp;ADT is associated with a wide range of side effects that can significantly impair quality of life. Important",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    frequent side effects include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Loss of lean body mass, increased body fat, and decreased muscle strength.",
"     </li>",
"     <li>",
"      Sexual dysfunction &mdash; Loss of libido in men receiving GnRH agonists usually develops within the first several months and is followed by erectile dysfunction.",
"     </li>",
"     <li>",
"      Loss of bone mineral density, which can result in bone fracture due to osteoporosis. This effect may be compounded by the presence of bone metastases.",
"     </li>",
"     <li>",
"      Vasomotor instability, which is manifested by hot flashes.",
"     </li>",
"     <li>",
"      Gynecomastia, decreased body hair, and smaller penile",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      testicular size.",
"     </li>",
"     <li>",
"      Fatigue or lack of energy.",
"     </li>",
"     <li>",
"      Behavioral and neurologic effects.",
"     </li>",
"     <li>",
"      Cardiovascular and metabolic abnormalities.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although these side effects are potentially significant, they should not preclude the use of ADT in appropriate clinical settings. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/30/21993?source=see_link\">",
"     \"Side effects of androgen deprivation therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16339642\">",
"    <span class=\"h2\">",
"     Timing of treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal time to initiate systemic therapy is uncertain. Hormone therapy for disseminated prostate cancer is not curative and immediate therapy has not been shown to prolong survival compared with delayed therapy. Furthermore, treatment-related side effects can adversely affect quality of life.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the setting of patients with overt metastatic disease, several randomized trials and a meta-analysis found that immediate compared to delayed ADT was associated with a statistically significant decrease in prostate cancer-related death although there was no overall survival benefit [",
"      <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/5\">",
"       5",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H25#H25\">",
"       \"Initial hormone therapy for metastatic prostate cancer\", section on 'Timing of ADT'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The optimal timing for the initiation of ADT for patients with a rising serum PSA is controversial. Proponents of early treatment argue that this approach can delay disease progression and may prolong survival. Others contend that treatment is best deferred until clinical metastases or symptoms develop since there is no consistent evidence for a significant survival benefit with ADT in this setting. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/48/30470?source=see_link&amp;anchor=H4#H4\">",
"       \"Rising serum PSA after treatment for localized prostate cancer: Systemic therapy\", section on 'Timing of ADT'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H261299899\">",
"    <span class=\"h1\">",
"     CASTRATE RESISTANT DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have evidence of disease progression (eg, increase in serum PSA, new clinical metastases, progression of existing metastases) while being managed with ADT are considered to have castrate resistant disease. The presence of castrate resistant disease does not imply that disease is totally independent of androgens and resistant to further therapies directed at the androgen stimulation of tumor growth. For patients whose initial ADT was a medical orchiectomy (GnRH agonist or antagonist), such treatment should be continued even when additional systemic treatment is initiated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38520?source=see_link&amp;anchor=H4#H4\">",
"     \"Secondary endocrine therapies for castration resistant prostate cancer\", section on 'Continuation of ADT'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prostate cancer can have a long natural history, and its management may require the sequential use of multiple treatment options. Factors to consider in sequencing these options are discussed separately. (See",
"    <a class=\"local\" href=\"#H261299183\">",
"     'Sequence of systemic therapies'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H200193122\">",
"    <span class=\"h2\">",
"     Interference with androgenic stimulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;An improved understanding of the role of androgens in stimulating the growth of prostate cancer has lead to the development of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"     enzalutamide",
"    </a>",
"    , both of which have significantly improved overall survival compared with placebo in phase III trials in patients with castrate resistant prostate cancer .",
"   </p>",
"   <p>",
"    There are no data on the activity of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"     enzalutamide",
"    </a>",
"    in patients who have previously been treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    , nor are there data on the activity of abiraterone after treatment with enzalutamide.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95566238\">",
"    <span class=\"h3\">",
"     Abiraterone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Androgens produced in the testis can cause",
"    <span class=\"nowrap\">",
"     &ldquo;autocrine/paracrine&rdquo;",
"    </span>",
"    signaling that results in tumor progression.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     Abiraterone",
"    </a>",
"    is an orally administered small molecule that irreversibly inhibits the products of the CYP17 gene (including both 17,20-lyase and 17-alpha-hydroxylase). In doing so, abiraterone blocks the synthesis of androgens in the tumor as well as in the testis and adrenal glands. Patients treated with abiraterone are at risk for adrenal insufficiency and require concurrent steroid replacement therapy. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16503?source=see_link&amp;anchor=H1409980#H1409980\">",
"     \"Castrate resistant prostate cancer: Treatments targeting the androgen pathway\", section on 'Abiraterone'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In two phase III trials,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    prolonged overall survival compared with prednisone alone in men who had previously been treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/6\">",
"     6",
"    </a>",
"    ] and in those who were chemotherapy na&iuml;ve [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/7\">",
"     7",
"    </a>",
"    ]. Abiraterone is approved for patients who have metastatic castrate resistant prostate cancer. Abiraterone is generally well tolerated, although fluid retention, hypokalemia and hypertension may require treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16503?source=see_link&amp;anchor=H1409980#H1409980\">",
"     \"Castrate resistant prostate cancer: Treatments targeting the androgen pathway\", section on 'Abiraterone'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     Abiraterone",
"    </a>",
"    has not been studied in patients who have previously been treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"     enzalutamide",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95567434\">",
"    <span class=\"h3\">",
"     Enzalutamide",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"     Enzalutamide",
"    </a>",
"    is an orally administered agent that acts at multiple sites in the androgen receptor signaling pathway, including blocking the binding of androgen to the androgen receptor, inhibition of nuclear translocation of the androgen receptor, and inhibition of the association of the androgen receptor with nuclear DNA. Unlike",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    , concurrent treatment with steroids is not required.",
"   </p>",
"   <p>",
"    In a phase III trial in men who had received prior",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    -based chemotherapy,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"     enzalutamide",
"    </a>",
"    significantly increased median survival compared with placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/8\">",
"     8",
"    </a>",
"    ]. A second phase III trial is evaluating enzalutamide in chemotherapy na&iuml;ve patients (NCT01212991) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/9\">",
"     9",
"    </a>",
"    ]. Treatment with enzalutamide has rarely been associated with seizures, and its use is contraindicated in patients with a seizure disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16503?source=see_link&amp;anchor=H1385299855#H1385299855\">",
"     \"Castrate resistant prostate cancer: Treatments targeting the androgen pathway\", section on 'Enzalutamide'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"     Enzalutamide",
"    </a>",
"    is approved for men with metastatic, castration-resistant prostate cancer who have received treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    . There are no data on the efficacy of enzalutamide in men who have previously been treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H176001\">",
"    <span class=\"h3\">",
"     Other endocrine approaches",
"    </span>",
"    &nbsp;&mdash;&nbsp;Older secondary endocrine treatment options include the addition of antiandrogens to patients treated with a GnRH antagonist alone or with surgical orchiectomy, withdrawal of antiandrogen therapy for patients who have been on an antiandrogen, suppression of adrenal androgen production with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/34/33312?source=see_link\">",
"     ketoconazole",
"    </a>",
"    or steroids, and estrogens or progesterones. Overall response rates, generally based upon changes in serum PSA, vary from 20 to 60 percent, and responses tend to be of relatively short duration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38520?source=see_link\">",
"     \"Secondary endocrine therapies for castration resistant prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Specific secondary endocrine treatment approaches generally have not been compared with each other in large randomized trials, nor has a survival benefit been demonstrated with these approaches. However, the sequential use of such endocrine treatments prior to switching to chemotherapy often is preferred because of the generally less severe side effects.",
"   </p>",
"   <p>",
"    These alternative approaches may be used immediately after ADT in patients who have evidence of slow progression as manifested only by an increasing PSA or have asymptomatic metastases. Secondary endocrine approaches may also have a role after chemotherapy in the later phases of disease when there are no other treatment options.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H176008\">",
"    <span class=\"h4\">",
"     Antiandrogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antiandrogens block the effects of circulating androgens with fewer adverse effects (hot flashes, loss of libido, impotence) than are associated with surgical or medical castration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38520?source=see_link&amp;anchor=H9#H9\">",
"     \"Secondary endocrine therapies for castration resistant prostate cancer\", section on 'Antiandrogens'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antiandrogens may be useful in patients whose initial ADT included either medical orchiectomy with a GnRH alone or surgical orchiectomy. There is incomplete cross-resistance between antiandrogens, and substitution of one antiandrogen for another occasionally is useful.",
"   </p>",
"   <p>",
"    Available nonsteroidal antiandrogens include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/23/4470?source=see_link\">",
"     flutamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/2/30758?source=see_link\">",
"     bicalutamide",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33204?source=see_link\">",
"     nilutamide",
"    </a>",
"    . The steroidal antiandrogen",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/2/14374?source=see_link\">",
"     cyproterone acetate",
"    </a>",
"    is approved for this indication outside the United States.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H176015\">",
"    <span class=\"h4\">",
"     Antiandrogen withdrawal",
"    </span>",
"    &nbsp;&mdash;&nbsp;The so-called \"antiandrogen withdrawal syndrome\" refers to a decline in serum PSA that is sometimes observed following the withdrawal of an antiandrogen in men who had progressed while being managed with complete androgen blockade. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38520?source=see_link&amp;anchor=H6#H6\">",
"     \"Secondary endocrine therapies for castration resistant prostate cancer\", section on 'Antiandrogen withdrawal'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Approximately 20 percent of men progressing after complete androgen blockade have a PSA or \"biochemical\" response when antiandrogens are withdrawn, and some experience symptomatic or objective improvement. For men who have progressed while on complete androgen blockade, the first therapeutic maneuver is the discontinuation of the antiandrogen. Other therapy generally should not be initiated until adequate time has elapsed to assess for a possible withdrawal response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H176029\">",
"    <span class=\"h4\">",
"     Ketoconazole",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/34/33312?source=see_link\">",
"     Ketoconazole",
"    </a>",
"    is an antifungal agent that inhibits adrenal androgen synthesis. Ketoconazole also has a direct cytotoxic effect on prostate cancer cells. Serum testosterone levels decline to castrate levels within 24 hours and antitumor efficacy is rapid. Adverse effects (nausea and vomiting, skin rash, fatigue, asthenia) and drug interactions may limit the use of ketoconazole in some patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38520?source=see_link&amp;anchor=H15#H15\">",
"     \"Secondary endocrine therapies for castration resistant prostate cancer\", section on 'Ketoconazole'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H176036\">",
"    <span class=\"h4\">",
"     Glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoids (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    ) reduce pituitary production of ACTH, resulting in suppression of adrenal steroidogenesis, including adrenal androgens. Several studies have shown significant subjective and objective improvement in men with castrate-resistant prostate cancer who receive glucocorticoids. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38520?source=see_link&amp;anchor=H19#H19\">",
"     \"Secondary endocrine therapies for castration resistant prostate cancer\", section on 'Glucocorticoids'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H176043\">",
"    <span class=\"h4\">",
"     Estrogens and progesterones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estrogens inhibit the release of gonadotropin releasing hormone (GnRH) from the hypothalamus, thus suppressing pituitary luteinizing hormone release and thereby reducing testicular production of testosterone.",
"   </p>",
"   <p>",
"    Diethylstilbestrol (DES) is no longer used at a dose of 5",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    in men with prostate cancer because of the increased risk of cardiovascular disease. However, DES at a dose of 1",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    is useful in some patients. Other estrogen preparations and progesterones also may have a role in occasional patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38520?source=see_link&amp;anchor=H20#H20\">",
"     \"Secondary endocrine therapies for castration resistant prostate cancer\", section on 'Estrogens'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38520?source=see_link&amp;anchor=H374890087#H374890087\">",
"     \"Secondary endocrine therapies for castration resistant prostate cancer\", section on 'Megestrol acetate'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H175284\">",
"    <span class=\"h2\">",
"     Sipuleucel-T",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/18/12581?source=see_link\">",
"     Sipuleucel-T",
"    </a>",
"    is a dendritic cell vaccine that is prepared from peripheral blood mononuclear cells obtained by leukapheresis. These cells are exposed ex vivo to a novel recombinant protein immunogen, which consists of prostatic acid phosphatase (PAP) fused to human granulocyte macrophage colony-stimulating factor. These activated cells are then infused back into the patient approximately three days after the original harvesting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/14/1254?source=see_link&amp;anchor=H3#H3\">",
"     \"Immunotherapy for castration resistant prostate cancer\", section on 'Sipuleucel-T'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In randomized trials,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/18/12581?source=see_link\">",
"     sipuleucel-T",
"    </a>",
"    prolonged overall survival compared with placebo in men with minimally symptomatic, metastatic prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/10\">",
"     10",
"    </a>",
"    ]. There are no data on the effectiveness of sipuleucel-T in men whose only evidence of disease is an elevated PSA or in those with symptomatic metastatic disease. Treatment is contraindicated in patients who are on steroids or opioids for cancer-related pain, and should be used with caution in patients with liver metastases.",
"   </p>",
"   <p>",
"    Although",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/18/12581?source=see_link\">",
"     sipuleucel-T",
"    </a>",
"    prolonged overall survival, it did not significantly increase progression-free survival or affect the serum PSA. Thus assessing the impact of therapy on an individual patient can be difficult or impossible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95567186\">",
"    <span class=\"h2\">",
"     Chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Taxanes are the only cytotoxic chemotherapy agents that significantly prolonged overall survival in clinical trials in men with castrate-resistant prostate cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6280?source=see_link\">",
"     \"Chemotherapy in castrate-resistant prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95567323\">",
"    <span class=\"h3\">",
"     Docetaxel",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     Docetaxel",
"    </a>",
"    (75",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    given every three weeks in combination with daily",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    (5 mg twice a day) significantly prolonged overall survival compared with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/31/37368?source=see_link\">",
"     mitoxantrone",
"    </a>",
"    plus prednisone in the TAX 327 phase III trial [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/11\">",
"     11",
"    </a>",
"    ]. Based upon those results, docetaxel plus prednisone has become the standard initial regimen when chemotherapy is indicated for castrate resistant prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6280?source=see_link&amp;anchor=H8#H8\">",
"     \"Chemotherapy in castrate-resistant prostate cancer\", section on 'Chemotherapy-naive patients: docetaxel'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     Docetaxel",
"    </a>",
"    causes significant myelosuppression and requires premedication to minimize the risk of infusion reactions. Therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    is also required in combination with docetaxel. Contraindications include underlying hepatic dysfunction or compromised bone marrow function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95567330\">",
"    <span class=\"h3\">",
"     Cabazitaxel",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/47/31478?source=see_link\">",
"     Cabazitaxel",
"    </a>",
"    is a synthetic taxane derivative developed to have activity in patients who progressed after treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    . In a phase III trial, cabazitaxel plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    significantly increased survival compared with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/31/37368?source=see_link\">",
"     mitoxantrone",
"    </a>",
"    plus prednisone in men whose disease had progressed on docetaxel [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6280?source=see_link&amp;anchor=H12#H12\">",
"     \"Chemotherapy in castrate-resistant prostate cancer\", section on 'Second-line chemotherapy: cabazitaxel'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/47/31478?source=see_link\">",
"     Cabazitaxel",
"    </a>",
"    can cause significant myelosuppression and requires premedication to minimize the risk of infusion reactions. Therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    is also required in combination with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    . Contraindications include underlying hepatic dysfunction or compromised bone marrow function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H175883\">",
"    <span class=\"h3\">",
"     Mitoxantrone",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/31/37368?source=see_link\">",
"     Mitoxantrone",
"    </a>",
"    was the first chemotherapy agent approved for use in men with castrate resistant prostate cancer. Mitoxantrone was approved based upon improvement in symptoms, and not a prolongation of survival. Its use now is restricted to patients requiring chemotherapy who have progressed on or are not candidates for taxane chemotherapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6280?source=see_link&amp;anchor=H66810582#H66810582\">",
"     \"Chemotherapy in castrate-resistant prostate cancer\", section on 'Mitoxantrone'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95566246\">",
"    <span class=\"h2\">",
"     Radium-223",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radium-223 is an alpha particle emitting radiopharmaceutical. Radium is a bone-seeking element, and radium-223&rsquo;s radioactive decay allows the deposition of high energy radiation over a much shorter distance than with beta-emitting radioisotopes, thus minimizing toxicity to normal bone marrow and to other organs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=see_link&amp;anchor=H261306118#H261306118\">",
"     \"Management of bone metastases in advanced prostate cancer\", section on 'Radium-223'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a phase III trial, treatment with radium-223 was well tolerated, decreased skeletal related complications (pathologic fractures, epidural spinal cord compression, need for external beam radiation therapy), and significantly improved overall survival in patients with two or more bone metastases and no known visceral metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/14\">",
"     14",
"    </a>",
"    ]. Because of its mechanism of action, its use is limited to patients who have symptomatic bone metastases without other clinically significant sites of disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=see_link&amp;anchor=H261306118#H261306118\">",
"     \"Management of bone metastases in advanced prostate cancer\", section on 'Radium-223'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Radium-223 is currently available only through an expanded access protocol for patients who have with symptomatic bone metastases who are not candidates for chemotherapy (NCT01516762).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4110342\">",
"    <span class=\"h1\">",
"     SURVEILLANCE DURING TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surveillance strategies during treatment for disseminated prostate cancer are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/52/10055?source=see_link&amp;anchor=H11088148#H11088148\">",
"     \"Follow-up surveillance during and after treatment for prostate cancer\", section on 'Metastatic prostate cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H501733343\">",
"    <span class=\"h1\">",
"     PROGNOSTIC BIOMARKERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of markers are being studied for their ability to identify subsets of patients with advanced prostate cancer who have significantly different prognosis. The most extensive data come from analyses of circulating tumor cells (CTCs); more recently, studies have looked at gene expression profiles. Ultimately, these different approaches may be combined. Currently, these studies cannot be used in individual patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H501733350\">",
"    <span class=\"h2\">",
"     Circulating tumor cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Circulating tumor cells (CTCs) producing PSA can be detected in the systemic circulation of men with prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/15\">",
"     15",
"    </a>",
"    ]. The impact of CTCs on prognosis was prospectively assessed using the CellSearch assay in the phase III trial comparing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    with placebo plus prednisone in men with castration-resistant metastatic prostate cancer who had progressed on",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    chemotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16503?source=see_link&amp;anchor=H1385299281#H1385299281\">",
"     \"Castrate resistant prostate cancer: Treatments targeting the androgen pathway\", section on 'Efficacy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    CTCs were measured in 972 of 1195 patients either at baseline and serially thereafter. Median overall survival was significantly longer in those with baseline CTCs &lt;5 compared with those with CTCs &ge;5 (22.1 versus 10.9 months in those assigned to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    and 19.7 versus 8.2 months in those assigned to placebo). Among patients with a CTCs &ge;5 at baseline, significantly more patients treated with abiraterone had a decrease in CTC level to &lt;5 compared with placebo (48 versus 17 percent at 12 weeks).",
"   </p>",
"   <p>",
"    Similarly, the level of CTCs was prognostic for overall survival in a second correlative study in 238 patients randomly assigned to treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    or docetaxel plus atrasentan [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The significance of circulating prostate cancer cells in men at the time of their initial diagnosis is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/30/9704?source=see_link\">",
"     \"Prostate cancer: Risk stratification, other prognostic factors, and predictive tools\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H501733357\">",
"    <span class=\"h2\">",
"     Gene expression panels",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have looked at the use of gene expression panels as a way to identify patient subsets with differing prognoses.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one report, a six gene panel was initially developed in a group of 62 men with castrate resistant prostate cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/18\">",
"       18",
"      </a>",
"      ]. The prognostic utility was then validated in an independent cohort of 138 patients. The use of the panel was able to divide this cohort into low and high risk groups, with median survivals of 9.2 and 18.5 months, respectively.",
"     </li>",
"     <li>",
"      In another study, a nine-gene was assessed in a two step process [",
"      <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/19\">",
"       19",
"      </a>",
"      ]. A patient subset (LPD1) was identified from the initial study. In the validation cohort, this panel found that those in this subset had a significantly poorer prognosis (median overall survival 11 versus 26 months).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H175876\">",
"    <span class=\"h1\">",
"     SMALL CELL CANCER OF PROSTATE",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with castrate resistant disease in whom small cell cancer is suspected, biopsy is indicated whenever possible. If the biopsy confirms that the tumor is a small cell malignancy, chemotherapy with a small cell regimen is indicated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/31/3578?source=see_link&amp;anchor=H6#H6\">",
"     \"Extrapulmonary small cell cancer\", section on 'Prostate ESCC'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF BONE METASTASES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteoblastic metastases to the axial skeleton are the predominant site of metastases in most men with prostate cancer. These lesions are frequently symptomatic and can cause pain, functional impairment, and debility. The goals of treatment are to relieve pain, improve mobility, and prevent complications such as pathologic fractures or epidural spinal cord compression. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/41/41622?source=see_link\">",
"     \"Bone metastases in advanced prostate cancer: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Systemic antitumor therapy may alleviate symptoms from bone metastases, but other treatments may also be needed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=see_link\">",
"     \"Management of bone metastases in advanced prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Radiation therapy",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      External beam RT &mdash; External beam RT is indicated for men with either a single or a few focally symptomatic bone metastases, when pain cannot be controlled with moderate analgesics. Local field RT provides some benefit in 80 to 90 percent of cases, and 50 to 60 percent have complete relief of symptoms. Repeated use of palliative RT, especially when given to areas encompassing much of the active marrow, can cause bone marrow suppression, which may impair quality of life and limit the use of palliative chemotherapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33924?source=see_link&amp;anchor=H2#H2\">",
"       \"Radiation therapy for the management of painful bone metastases\", section on 'External beam RT'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Radiopharmaceuticals &mdash; The alpha-particle emitting radiopharmaceutical radium-223 decreases bone pain and delays or prevents the complications of bone metastases. (See",
"      <a class=\"local\" href=\"#H95566246\">",
"       'Radium-223'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=see_link&amp;anchor=H261306118#H261306118\">",
"       \"Management of bone metastases in advanced prostate cancer\", section on 'Radium-223'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The beta-particle emitting radioisotopes samarium-153 (153Sm) and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/14/26851?source=see_link\">",
"       strontium-89",
"      </a>",
"      (89Sr) have been used for palliative treatment of patients with multifocal, painful osteoblastic bone metastases and those with persistent or recurrent pain despite receiving external beam RT to maximal normal tissue tolerance. However, the role of these agents is less clear with the development of alpharadin. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=see_link&amp;anchor=H261305535#H261305535\">",
"       \"Management of bone metastases in advanced prostate cancer\", section on 'Beta emitting radiopharmaceuticals'",
"      </a>",
"      .)",
"      <br/>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92309407\">",
"    <span class=\"h2\">",
"     Osteoclast inhibition",
"    </span>",
"    &nbsp;&mdash;&nbsp;For men with bone metastases, the use of an osteoclast inhibitor (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/1/9241?source=see_link\">",
"     zoledronic acid",
"    </a>",
"    ) is an important adjunct to reduce the risk of skeletal complications of bone metastases.(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=see_link&amp;anchor=H19250956#H19250956\">",
"     \"Management of bone metastases in advanced prostate cancer\", section on 'Osteoclast inhibition'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92309354\">",
"    <span class=\"h2\">",
"     Analgesics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of pain in men with advanced prostate cancer should prompt immediate and aggressive management with analgesics while local or systemic treatments that directly address the cause of the pain are pursued. The use of nonopioid analgesics, opioids, and analgesic adjuvants is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/7/30842?source=see_link\">",
"     \"Cancer pain management with opioids: Optimizing analgesia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4488?source=see_link\">",
"     \"Cancer pain management: Use of acetaminophen and nonsteroidal antiinflammatory drugs\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/9/39066?source=see_link\">",
"     \"Cancer pain management: Adjuvant analgesics (coanalgesics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     PALLIATION OF PELVIC DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advanced prostate cancer can cause pelvic symptoms that significantly impair quality of life. These include lower urinary tract symptoms, pelvic pain, hematuria, and obstructive rectal symptoms. Systemic therapy is the primary approach for the control of such symptoms. (See",
"    <a class=\"local\" href=\"#H25221296\">",
"     'Androgen deprivation therapy'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H261299899\">",
"     'Castrate resistant disease'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Although there are no prospective clinical studies in patients with castrate-resistant prostate cancer, retrospective series indicate that RT may be useful for symptom palliation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. As an example, in one series 58 men were treated with 20 Gy in five fractions [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/20\">",
"     20",
"    </a>",
"    ]. Four months after RT, 31 of 35 patients (89 percent) had complete resolution of symptoms. In a second series, a more protracted RT schedule (2 Gy fractions, median dose 60 Gy) gave similar results [",
"    <a class=\"abstract\" href=\"UTD.htm?10/12/10442/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?2/3/2099?source=see_link\">",
"       \"Patient information: Prostate cancer (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?39/39/40565?source=see_link\">",
"       \"Patient information: Prostate cancer treatment; stage I to III cancer (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?41/41/42643?source=see_link\">",
"       \"Patient information: Treatment for advanced prostate cancer (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although most men with prostate cancer are diagnosed and successfully treated while disease is localized, some will present with or subsequently develop disseminated disease. This is often manifested initially by an increasing PSA in patients who are being closely followed for evidence of recurrence after definitive treatment. In other cases, however, overt metastatic disease may be present when the patient is first diagnosed or at some time after definitive treatment for locoregional disease. The same treatment options are generally used for men with overt metastases and those whose only evidence of disease is an elevated or rising serum PSA. (See",
"      <a class=\"local\" href=\"#H261299175\">",
"       'Patient populations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Previously untreated prostate cancer generally is dependent upon androgen for its continued growth. This observation provides the basis for androgen deprivation therapy (ADT) as the initial systemic therapy. Treatments targeting androgenic stimulation of the tumor are also used in several subsequent treatment modalities. (See",
"      <a class=\"local\" href=\"#H25221296\">",
"       'Androgen deprivation therapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H200193122\">",
"       'Interference with androgenic stimulation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend initial treatment with either medical or surgical orchiectomy (androgen deprivation therapy [ADT]) to suppress serum testosterone levels for all patients requiring systemic therapy (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). This approach replaced estrogen therapy, which was associated with increased cardiovascular toxicity in randomized trials. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H6#H6\">",
"       \"Initial hormone therapy for metastatic prostate cancer\", section on 'Surgical orchiectomy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H7#H7\">",
"       \"Initial hormone therapy for metastatic prostate cancer\", section on 'Medical orchiectomy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Other modalities that have been shown to prolong survival in men with castrate resistant disease have not been evaluated as initial therapy and are not indicated in this setting (",
"      <a class=\"graphic graphic_table graphicRef85716 \" href=\"UTD.htm?17/56/18317\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H261299639\">",
"       'Castrate resistant disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The optimal timing for therapeutic intervention depends upon the extent of disease as well as patient specific factors:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For men with overt metastases, we suggest early treatment with ADT rather than delayed treatment (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). This approach has been shown to delay prostate cancer related deaths, but has not been shown to improve overall survival. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link&amp;anchor=H25#H25\">",
"       \"Initial hormone therapy for metastatic prostate cancer\", section on 'Timing of ADT'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For men whose only evidence of disseminated disease is an elevated or rising PSA following definitive locoregional therapy, the optimal timing for initiation of ADT is more problematic and involves a consideration of the prolonged natural history of the disease as well as patient specific factors including age and personal preferences. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/48/33544?source=see_link&amp;anchor=H81453304#H81453304\">",
"       \"Rising serum PSA following local therapy for prostate cancer: Definition, natural history, and risk stratification\", section on 'Prognosis after biochemical failure'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/48/30470?source=see_link&amp;anchor=H4#H4\">",
"       \"Rising serum PSA after treatment for localized prostate cancer: Systemic therapy\", section on 'Timing of ADT'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Castrate resistant prostate cancer is defined by the occurrence of disease progression after surgical or medical orchiectomy. The presence of castrate resistant disease does not imply that disease is totally independent of androgens and resistant to further therapies directed at blocking androgen stimulation. ADT should be continued when additional systemic therapy is used in men with castrate resistant disease. (See",
"      <a class=\"local\" href=\"#H261299899\">",
"       'Castrate resistant disease'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38520?source=see_link&amp;anchor=H4#H4\">",
"       \"Secondary endocrine therapies for castration resistant prostate cancer\", section on 'Continuation of ADT'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For men with castrate resistant prostate cancer, we recommend that therapy sequentially incorporate modalities that have been demonstrated to improve overall survival, and the choice of therapy should be guided by the patient population studied in clinical trials (",
"      <a class=\"graphic graphic_table graphicRef85716 \" href=\"UTD.htm?17/56/18317\">",
"       table 1",
"      </a>",
"      ). Potential options include interference with androgenic stimulation of tumor growth (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"       abiraterone",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"       enzalutamide",
"      </a>",
"      ),",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/18/12581?source=see_link\">",
"       sipuleucel-T",
"      </a>",
"      , taxane chemotherapy (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"       docetaxel",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/47/31478?source=see_link\">",
"       cabazitaxel",
"      </a>",
"      ), and radium-223. Older approaches that may have a role in selected cases include antiandrogens, antiandrogen withdrawal, suppression of adrenal steroidogenesis with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/34/33312?source=see_link\">",
"       ketoconazole",
"      </a>",
"      or steroids, estrogens, and progesterones. (See",
"      <a class=\"local\" href=\"#H261299899\">",
"       'Castrate resistant disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Factors that should be considered include the site and extent of disease, rate of disease progression, symptomatology, comorbidities, rate of disease progression, regulatory status and availability of the modality, side effects of the treatment, and contraindications. (See",
"      <a class=\"local\" href=\"#H261299183\">",
"       'Sequence of systemic therapies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Osteoblastic lesions in the axial skeleton are the predominant site of metastases in the majority of cases. For men with bone metastases, the use of an osteoclast inhibitor is an important adjunct to systemic therapy to reduce the risk of skeletal complications (pathologic fracture, epidural spinal cord compression). In addition, external beam radiation or radiopharmaceuticals may provide important symptom palliation for men with severe pain at one or more sites due to bone metastases. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=see_link\">",
"       \"Management of bone metastases in advanced prostate cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/1\">",
"      Sweeney C. Prostate cancer therapy: going forwards by going backwards. Lancet Oncology 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/2\">",
"      Gravis G, Fizazi K, Joly F, et al. Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial. Lancet Oncol 2013; 14:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/3\">",
"      Hussain M, Tangen CM, Berry DL, et al. Intermittent versus continuous androgen deprivation in prostate cancer. N Engl J Med 2013; 368:1314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/4\">",
"      Klotz L, O'Callaghan CJ, Ding K. A phase III randomized trial comparing intermittent versus continuous androgen suppression for patients with PSA progression after radical therapy: NCIC CTG PR.7/SWOG  JPR.7/CTSU JPR.7/UK Intercontinental Trial CRUKE/01/013 (abstract #3). J Clin Oncol 2011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/5\">",
"      Loblaw DA, Virgo KS, Nam R, et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2007; 25:1596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/6\">",
"      de Bono JS, Logothetis CJ, Molina A, et al. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 2011; 364:1995.",
"     </a>",
"    </li>",
"    <li>",
"     Ryan CJ, et al. Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate (AA) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). J Clin Oncol 2012; (suppl: abstract LBA 4518).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/8\">",
"      Scher HI, Fizazi K, Saad F, et al. Effect of MDV3100, an androgen receptor signaling inhibitor (ARSI), on overall survival in patients with prostate cancer postdocetaxel: Results from the phase III AFFIRM study. J Clin Oncol 2012; 30.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.clinicaltrials.gov/ (Accessed on July 03, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/10\">",
"      Kantoff PW, Higano CS, Shore ND, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 2010; 363:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/11\">",
"      Berthold DR, Pond GR, Soban F, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study. J Clin Oncol 2008; 26:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/12\">",
"      Basch EM, Somerfield MR, Beer TM, et al. American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer. J Clin Oncol 2007; 25:5313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/13\">",
"      de Bono JS, Oudard S, Ozguroglu M, et al. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet 2010; 376:1147.",
"     </a>",
"    </li>",
"    <li>",
"     Parker C, et al. Overall survival benefit of radium-223 chloride (Alpharadin) in the treatment of patients with symptomatic bone metastases in castration-resistant prostate cancer: A phase III randomized trial (ALSYMPCA). Abstract 1LBA, European Multidisciplinary Congress, 2011.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/15\">",
"      de Bono JS, Scher HI, Montgomery RB, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 2008; 14:6302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/16\">",
"      Scher HI, et al. Evaluation of circulating tumor cell (CTCs) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel. J Clin Oncol 2011; 29:293s.",
"     </a>",
"    </li>",
"    <li>",
"     Vogelzang NJ, Ely B, Fink LM, et al. Circulating tumor cell counts (CTC) as prognostic of overall survival (OS) in SWOG S0421-docetaxel with or without atrasentan for metastatic castration resistant prostate cancer (mCRPC). J Clin Oncol 30, 2012 (suppl; abstr 10503).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/18\">",
"      Ross RW, Galsky MD, Scher HI, et al.. A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study. Lancet Oncol 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/19\">",
"      Olmos D, Brewer D, Danila DC, et al. Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study. Lancet Oncol 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/20\">",
"      Din OS, Thanvi N, Ferguson CJ, Kirkbride P. Palliative prostate radiotherapy for symptomatic advanced prostate cancer. Radiother Oncol 2009; 93:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/12/10442/abstract/21\">",
"      Hindson B, Turner S, Do V. Palliative radiation therapy for localized prostate symptoms in hormone refractory prostate cancer. Australas Radiol 2007; 51:584.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6941 Version 21.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-58.240.98.179-2FE80B8408-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10442=[""].join("\n");
var outline_f10_12_10442=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H37\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H261299175\">",
"      PATIENT POPULATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H261299183\">",
"      SEQUENCE OF SYSTEMIC THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H261299582\">",
"      Androgen deprivation therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H261299639\">",
"      Castrate resistant disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25221296\">",
"      ANDROGEN DEPRIVATION THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Bilateral orchiectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Medical orchiectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Combined androgen blockade",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H456228329\">",
"      ADT plus chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Continuous versus intermittent ADT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Side effects of ADT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16339642\">",
"      Timing of treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H261299899\">",
"      CASTRATE RESISTANT DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H200193122\">",
"      Interference with androgenic stimulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H95566238\">",
"      - Abiraterone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H95567434\">",
"      - Enzalutamide",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H176001\">",
"      - Other endocrine approaches",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H176008\">",
"      Antiandrogens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H176015\">",
"      Antiandrogen withdrawal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H176029\">",
"      Ketoconazole",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H176036\">",
"      Glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H176043\">",
"      Estrogens and progesterones",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H175284\">",
"      Sipuleucel-T",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H95567186\">",
"      Chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H95567323\">",
"      - Docetaxel",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H95567330\">",
"      - Cabazitaxel",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H175883\">",
"      - Mitoxantrone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H95566246\">",
"      Radium-223",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4110342\">",
"      SURVEILLANCE DURING TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H501733343\">",
"      PROGNOSTIC BIOMARKERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H501733350\">",
"      Circulating tumor cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H501733357\">",
"      Gene expression panels",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H175876\">",
"      SMALL CELL CANCER OF PROSTATE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      MANAGEMENT OF BONE METASTASES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H92309407\">",
"      Osteoclast inhibition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H92309354\">",
"      Analgesics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      PALLIATION OF PELVIC DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/6941\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/6941|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/56/18317\" title=\"table 1\">",
"      Therapies for castrate resistant prostate cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/41/41622?source=related_link\">",
"      Bone metastases in advanced prostate cancer: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/7/30842?source=related_link\">",
"      Cancer pain management with opioids: Optimizing analgesia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/9/39066?source=related_link\">",
"      Cancer pain management: Adjuvant analgesics (coanalgesics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4488?source=related_link\">",
"      Cancer pain management: Use of acetaminophen and nonsteroidal antiinflammatory drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16503?source=related_link\">",
"      Castrate resistant prostate cancer: Treatments targeting the androgen pathway",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6280?source=related_link\">",
"      Chemotherapy in castrate-resistant prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/31/3578?source=related_link\">",
"      Extrapulmonary small cell cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/52/10055?source=related_link\">",
"      Follow-up surveillance during and after treatment for prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/14/1254?source=related_link\">",
"      Immunotherapy for castration resistant prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16969?source=related_link\">",
"      Initial approach to low-risk clinically localized prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=related_link\">",
"      Initial hormone therapy for metastatic prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/26/21930?source=related_link\">",
"      Initial management of regionally localized intermediate and high risk prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/8/36999?source=related_link\">",
"      Management of bone metastases in advanced prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/3/2099?source=related_link\">",
"      Patient information: Prostate cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/39/40565?source=related_link\">",
"      Patient information: Prostate cancer treatment; stage I to III cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/41/42643?source=related_link\">",
"      Patient information: Treatment for advanced prostate cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/30/9704?source=related_link\">",
"      Prostate cancer: Risk stratification, other prognostic factors, and predictive tools",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33924?source=related_link\">",
"      Radiation therapy for the management of painful bone metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/48/30470?source=related_link\">",
"      Rising serum PSA after treatment for localized prostate cancer: Systemic therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/48/33544?source=related_link\">",
"      Rising serum PSA following local therapy for prostate cancer: Definition, natural history, and risk stratification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38520?source=related_link\">",
"      Secondary endocrine therapies for castration resistant prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/30/21993?source=related_link\">",
"      Side effects of androgen deprivation therapy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_12_10443="Manifestations opioid toxicity";
var content_f10_12_10443=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F56801&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F56801&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical manifestations of opioid toxicity",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        System",
"       </td>",
"       <td class=\"subtitle1\">",
"        Manifestations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary",
"       </td>",
"       <td>",
"        Respiratory depression, bronchospasm, noncardiogenic pulmonary edema",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiovascular",
"       </td>",
"       <td>",
"        Orthostatic hypotension, peripheral vasodilation, dysrhythmias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurologic",
"       </td>",
"       <td>",
"        Analgesia, euphoria, dysphoria, miosis, mydriasis, seizures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastrointestinal",
"       </td>",
"       <td>",
"        Nausea, vomiting, constipation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dermatologic",
"       </td>",
"       <td>",
"        Flushing, pruritus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reproductive",
"       </td>",
"       <td>",
"        Amenorrhea, anovulation",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10443=[""].join("\n");
var outline_f10_12_10443=null;
var title_f10_12_10444="Clinical summary manual defibrillation in children";
var content_f10_12_10444=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F50341&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F50341&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical summary: Manual defibrillation in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        1. Perform defibrillation in children with ventricular fibrillation or ventricular tachycardia prior to establishing intravenous access or securing a definitive airway.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Apply electrode conduction paste or gel to the paddles or open the electrode pads.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Turn the machine on.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. If using paddles, select \"quick look\" to assess rhythm.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Apply paddles or pad to appropriate positions on chest (anterior pad or paddle to right of sternum just under the clavicle, apex pad or paddle in the midaxillary line at the level of the nipple). Paddles must be applied firmly*.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6. If ventricular fibrillation or ventricular tachycardia without a pulse is seen on the monitor, select an initial energy dose of 2 Joules/kg.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7. Charge unit by simultaneously pressing the charge button on the paddles or by pressing the charge button on the machine if electrode pads are being used.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8. Ensure all personnel are clear from the patient and the patient's stretcher by loudly stating \"All Clear!\" prior to shock delivery.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        9. Deliver current by either depressing discharge buttons simultaneously on the paddles or by pressing the discharge button on the machines if electrode pads are being used.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10. Assess clinical and electrical response to shock delivery.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        11. Initiate or resume basic cardiopulmonary resuscitation if shock unsuccessful and proceed according to pediatric advanced life support guidelines.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Anterior/posterior paddle position is acceptable but less practical during a critical resuscitation.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Scarfone RJ, Cho CS. Cardioversion and Defibrillation. In: Textbook of Pediatric Emergency Procedures, 2nd ed, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10444=[""].join("\n");
var outline_f10_12_10444=null;
var title_f10_12_10445="Adult abdominal and pelvic effective doses";
var content_f10_12_10445=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F69998&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F69998&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Adult abdominal and pelvic effective doses",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Procedure",
"       </td>",
"       <td class=\"subtitle1\">",
"        Modality",
"       </td>",
"       <td class=\"subtitle1\">",
"        Average effective dose (mSv)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Number of chest x-rays (PA/lateral) with equivalent radiation dose*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pelvic radiograph",
"       </td>",
"       <td>",
"        Conventional radiography",
"       </td>",
"       <td>",
"        0.6",
"       </td>",
"       <td>",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abdominal radiograph",
"       </td>",
"       <td>",
"        Conventional radiography",
"       </td>",
"       <td>",
"        0.7",
"       </td>",
"       <td>",
"        7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intravenous pyelogram",
"       </td>",
"       <td>",
"        Conventional radiography",
"       </td>",
"       <td>",
"        2.5",
"       </td>",
"       <td>",
"        25",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renogram",
"       </td>",
"       <td>",
"        Nuclear medicine",
"       </td>",
"       <td>",
"        2.6",
"       </td>",
"       <td>",
"        26",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HIDA scan",
"       </td>",
"       <td>",
"        Nuclear medicine",
"       </td>",
"       <td>",
"        3.1",
"       </td>",
"       <td>",
"        31",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        ERCP",
"       </td>",
"       <td>",
"        Conventional fluoroscopy or interventional radiology",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        40",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Small bowel follow through",
"       </td>",
"       <td>",
"        Conventional fluoroscopy or interventional radiology",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Upper gastrointestinal series",
"       </td>",
"       <td>",
"        Conventional fluoroscopy or interventional radiology",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CT pelvis",
"       </td>",
"       <td>",
"        Computed tomography",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GI bleeding study",
"       </td>",
"       <td>",
"        Nuclear medicine",
"       </td>",
"       <td>",
"        7.8",
"       </td>",
"       <td>",
"        78",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Barium enema",
"       </td>",
"       <td>",
"        Conventional fluoroscopy or interventional radiology",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CT abdomen",
"       </td>",
"       <td>",
"        Computed tomography",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abdominal angiogram",
"       </td>",
"       <td>",
"        Conventional fluoroscopy or interventional radiology",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        120",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Whole body PET",
"       </td>",
"       <td>",
"        Nuclear medicine",
"       </td>",
"       <td>",
"        14.1",
"       </td>",
"       <td>",
"        141",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CT triphasic liver",
"       </td>",
"       <td>",
"        Computed tomography",
"       </td>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        150",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CT angiogram aorta",
"       </td>",
"       <td>",
"        Computed tomography",
"       </td>",
"       <td>",
"        24",
"       </td>",
"       <td>",
"        240",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ERCP: endoscopic retrograde cholangiopancreatography; HIDA: hepatobiliary aminodiacetic acid; PET: positron-emission tomography.",
"     <br>",
"      * PA and lateral chest radiograph = .1 mSv.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Mettler, FA, Huda, W, Yoshizumi, TT, Mahesh, M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 2008; 248:254.",
"       </li>",
"       <li>",
"        Smith-Bindman, R, Lipson, J, Marcus, R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009; 169:2078.",
"       </li>",
"       <li>",
"        Shrimpton, PC, Hillier, MC, Lewis, MA, Dunn, M. National survey of doses from CT in the UK: 2003. Br J Radiol 2006; 79:968.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10445=[""].join("\n");
var outline_f10_12_10445=null;
var title_f10_12_10446="RLL BAC PET";
var content_f10_12_10446=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F70885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F70885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bronchioloalveolar carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 264px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Coronal view of PET scan shows intense uptake of FDG in the right lower lobe. The left sided activity in the left ventricle (arrow) is normal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10446=[""].join("\n");
var outline_f10_12_10446=null;
var title_f10_12_10447="Slit lamp focusing rod";
var content_f10_12_10447=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F72486&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F72486&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Slit lamp focusing rod",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 240px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The focusing rod enables the clinician to obtain consistent focusing from one slit lamp examination to the next.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin J Knoop, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_12_10447=[""].join("\n");
var outline_f10_12_10447=null;
